<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CTLA4 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>CTLA4</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/P16410" target="_blank" class="term-link">
                        P16410
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-in-progress">
                    IN PROGRESS
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "CTLA4";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="P16410" data-a="DESCRIPTION: CTLA4 (cytotoxic T-lymphocyte-associated protein 4..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>CTLA4 (cytotoxic T-lymphocyte-associated protein 4, CD152) encodes a type I transmembrane inhibitory co-receptor of the immunoglobulin superfamily. CTLA4 contains an extracellular Ig-like V-type domain that binds B7 family ligands CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells with higher avidity than the stimulatory co-receptor CD28, thereby competitively inhibiting T cell co-stimulation at the priming phase (PMID:11279501, PMID:11279502). CTLA4 functions as a disulfide-linked homodimer. Its surface expression is tightly regulated by constitutive clathrin-mediated endocytosis and recycling; at steady state it resides largely in intracellular vesicles (Golgi, endosomes, perinuclear region), with surface expression induced upon T cell activation. CTLA4 is constitutively expressed on FoxP3+ regulatory T cells (Tregs), where it mediates suppressive function including trans-endocytosis of CD80/CD86 from dendritic cells (CTLA4-deep-research-falcon.md). The cytoplasmic tail contains a YVKM motif whose phosphorylation at Tyr-201 by TXK and JAK2 regulates AP-2 binding and endocytic trafficking. Haploinsufficiency causes IDAIL (immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation), and common variants confer susceptibility to type 1 diabetes, Graves disease, celiac disease, and SLE. Anti-CTLA4 antibodies (ipilimumab, tremelimumab) are used in cancer immunotherapy; CTLA4-Ig fusions (abatacept, belatacept) are used to treat autoimmunity and prevent transplant rejection.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009897" target="_blank" class="term-link">
                                    GO:0009897
                                </a>
                            </span>
                            <span class="term-label">external side of plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0009897" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CTLA4 is detected on the external side of the plasma membrane of T cells upon activation. IBA annotation is supported by phylogenetic inference from CTLA4 orthologs including mouse Ctla4 and human CD28. Multiple experimental studies confirm CTLA4 surface expression, including flow cytometry studies (PMID:18641304) and structural studies showing the extracellular domain in complex with B7 ligands (PMID:11279501, PMID:11279502). UniProt notes CTLA4 is a cell membrane single-pass type I membrane protein with regulated surface expression. The deep research report (CTLA4-deep-research-falcon.md) confirms CTLA4 resides largely in intracellular vesicles at steady state with regulated surface expression.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Well-supported localization. CTLA4 is a transmembrane receptor whose extracellular Ig-like domain binds B7 ligands on APCs at the cell surface. IBA annotation is consistent with direct experimental evidence from structural studies and flow cytometry.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the 3.2-A resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link">
                                        PMID:18641304
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045590" target="_blank" class="term-link">
                                    GO:0045590
                                </a>
                            </span>
                            <span class="term-label">negative regulation of regulatory T cell differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0045590" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IBA annotation for negative regulation of Treg differentiation. CTLA4 is constitutively expressed on Tregs and plays complex roles in Treg biology. PMID:18641304 showed that activated CD4+CD25- T cells acquiring CTLA4 expression gain suppressive capacity, suggesting CTLA4 may regulate the threshold for Treg-like function. CTLA4 haploinsufficiency leads to dysregulated Treg function. However, CTLA4 is also required for Treg suppressive function, so its role in negatively regulating Treg differentiation is nuanced. The IBA annotation is phylogenetically supported and consistent with the IDA annotation from PMID:18641304.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Phylogenetically supported by IBA and consistent with the experimental IDA annotation from PMID:18641304 already in the annotation set. CTLA4 engagement can modulate the balance of Treg differentiation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link">
                                        PMID:18641304
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050852" target="_blank" class="term-link">
                                    GO:0050852
                                </a>
                            </span>
                            <span class="term-label">T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050852" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CTLA4 is a key modulator of T cell receptor signaling. It competes with CD28 for B7 ligand binding to attenuate TCR-dependent T cell activation (PMID:11279501, PMID:11279502). Phosphorylation of its cytoplasmic YVKM motif recruits PI3K and SHP-2 phosphatase, directly modulating TCR downstream signaling. IBA annotation is well-supported.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CTLA4 is a central component of the TCR co-stimulatory signaling axis. Its engagement with B7 ligands directly modulates TCR signaling output. Phylogenetically conserved function supported by extensive literature.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Regulation of T-cell activity is dependent on antigen-independent co-stimulatory signals provided by the disulphide-linked homodimeric T-cell surface receptors, CD28 and CTLA-4</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                        PMID:11279502
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Signalling through CD28 augments the T-cell response, whereas CTLA-4 signalling attenuates it</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050853" target="_blank" class="term-link">
                                    GO:0050853
                                </a>
                            </span>
                            <span class="term-label">B cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050853" data-r="GO_REF:0000033" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IBA annotation for B cell receptor signaling pathway. CTLA4 is primarily a T cell receptor. PMID:17875758 reported CTLA4 expression in B-CLL cells and found CTLA4 overexpression associated with good clinical outcome, but this study examined CTLA4 as a differentially expressed gene in CLL cells rather than demonstrating a direct mechanistic role in BCR signaling. CTLA4 expression on B cells has been reported but is not a core function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CTLA4 is primarily a T cell co-inhibitory receptor. While expression on B cells has been reported (PMID:17875758), its primary evolved function is in T cell biology. CTLA4 does not have a well-established direct role in BCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                                        PMID:17875758
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the overexpression of CTLA4 and MNDA was associated with good outcome</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002250" target="_blank" class="term-link">
                                    GO:0002250
                                </a>
                            </span>
                            <span class="term-label">adaptive immune response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0002250" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from UniProt keyword mapping (KW-1064 Adaptive immunity). CTLA4 is a central regulator of adaptive immune responses, specifically T cell activation. This is a broad but accurate annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CTLA4 is unquestionably involved in adaptive immunity as a key checkpoint receptor on T cells. While broad, this term is accurate and appropriately captures the biological context. More specific annotations (negative regulation of T cell activation, etc.) are also present to provide detail.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002376" target="_blank" class="term-link">
                                    GO:0002376
                                </a>
                            </span>
                            <span class="term-label">immune system process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0002376" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from UniProt keyword mapping (KW-0391 Immunity). Very broad term. CTLA4 is clearly involved in immune system processes. More specific terms are already annotated.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Very broad but correct. More informative child terms (adaptive immune response, negative regulation of T cell activation, etc.) are already annotated, making this redundant but not incorrect. Acceptable as an IEA.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from UniProt subcellular location vocabulary mapping. CTLA4 is a type I transmembrane protein localized to the plasma membrane. This is well-supported by UniProt annotation and multiple experimental studies.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization. CTLA4 is a single-pass type I membrane protein confirmed at the plasma membrane by multiple structural and cell biological studies (PMID:11279501, PMID:11279502, PMID:28484017).
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006955" target="_blank" class="term-link">
                                    GO:0006955
                                </a>
                            </span>
                            <span class="term-label">immune response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0006955" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from InterPro domain mapping (IPR008096 CTLA4). Broad but correct. CTLA4 is a key immune regulator. More specific terms are present.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Broad but accurate IEA. More specific terms provide the detail. The InterPro mapping from the CTLA4 domain correctly identifies immune function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009897" target="_blank" class="term-link">
                                    GO:0009897
                                </a>
                            </span>
                            <span class="term-label">external side of plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000117
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0009897" data-r="GO_REF:0000117" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from ARBA machine learning model. Consistent with the IBA annotation for the same term and experimental evidence from IDA (PMID:18641304). CTLA4 extracellular domain is exposed on the cell surface.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct and consistent with other evidence sources (IBA and IDA annotations for the same term). CTLA4 extracellular domain binds B7 ligands at the cell surface.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0016020" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from InterPro domain mapping (IPR008096 CTLA4). Very broad CC term. CTLA4 is indeed a membrane protein. More specific terms (plasma membrane, external side of plasma membrane) are already annotated.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Very broad but correct. CTLA4 is a transmembrane protein. More specific membrane localizations are captured by other annotations.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042129" target="_blank" class="term-link">
                                    GO:0042129
                                </a>
                            </span>
                            <span class="term-label">regulation of T cell proliferation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0042129" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from InterPro domain mapping (IPR040216 CTLA4/CD28). CTLA4 is a well-established negative regulator of T cell proliferation. The neutral &#34;regulation&#34; rather than &#34;negative regulation&#34; is acceptable for an IEA, though the more specific term GO:0042130 (negative regulation of T cell proliferation) is also present via Ensembl IEA transfer.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct. CTLA4 is a major regulator (specifically negative regulator) of T cell proliferation. The broader &#34;regulation&#34; term is acceptable for an InterPro-derived IEA since the family includes both CD28 (positive) and CTLA4 (negative).
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279501
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural basis for co-stimulation by the human CTLA-4/B7-2...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:11279501" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD86 (P42081). PMID:11279501 (Schwartz et al. 2001) determined the 3.2A crystal structure of the CTLA4/B7-2 (CD86) complex, providing direct structural evidence for this interaction. This is a core functional interaction for CTLA4. The term &#34;protein binding&#34; is uninformative; the interaction with CD86 is better captured by the receptor decoy activity annotation (GO:0140319).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While the physical interaction is real and well-documented by crystal structure, the term &#34;protein binding&#34; (GO:0005515) is uninformative per GO curation guidelines. The functional significance of this interaction is better captured by receptor decoy activity (GO:0140319) and signaling receptor inhibitor activity. The IPI annotation is a consequence of IntAct import and adds little beyond what is captured by more specific MF terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the 3.2-A resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279502
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Crystal structure of the B7-1/CTLA-4 complex that inhibits h...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:11279502" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD80 (P33681). PMID:11279502 (Stamper et al. 2001) determined the 3.0A crystal structure of the CTLA4/B7-1 (CD80) complex. Core functional interaction, but &#34;protein binding&#34; is uninformative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same reasoning as the CTLA4-CD86 interaction. The physical interaction is real but &#34;protein binding&#34; is uninformative. Functional significance captured by receptor decoy activity (GO:0140319).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                        PMID:11279502
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the crystal structure of the human CTLA-4/B7-1 co-stimulatory complex at 3.0 A resolution</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20587542" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20587542
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    PD-L1 and PD-L2 differ in their molecular mechanisms of inte...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:20587542" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD80 (P33681). PMID:20587542 (Ghiotto et al. 2010) is primarily a study of PD-L1 and PD-L2 interaction mechanisms with PD-1 but also detected CTLA4-CD80 interaction. The CTLA4-CD80 interaction is well-established by structural studies.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. The CTLA4-CD80 interaction is well-established and functionally captured by receptor decoy activity (GO:0140319).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20587542" target="_blank" class="term-link">
                                        PMID:20587542
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PD-L1 behaved in a similar manner with its second ligand, CD80 [study also detected CTLA4 interactions with CD80]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/21982860" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:21982860
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A secreted protein microarray platform for extracellular pro...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:21982860" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD80 (P33681) and CD86 (P42081). PMID:21982860 is a secreted protein microarray platform study. High-throughput detection of known interactions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. CTLA4 interactions with CD80 and CD86 are well-documented by structural studies and are functionally captured by more specific MF terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21982860" target="_blank" class="term-link">
                                        PMID:21982860
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">we screened a set of 89 immunoglobulin (Ig)-type receptors against a highly diverse extracellular protein microarray with 686 genes represented</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25241761" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25241761
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Using an in situ proximity ligation assay to systematically ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:25241761" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD86 (P42081). PMID:25241761 used in situ proximity ligation assay (PLA) to systematically profile protein-protein interactions. Confirms the known CTLA4-CD86 interaction.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. The CTLA4-CD86 interaction is functionally captured by receptor decoy activity and other specific terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/25241761" target="_blank" class="term-link">
                                        PMID:25241761
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Herein, we collected ‚àº 700 primary antibodies and employed a highly sensitive and specific technique, an in situ proximity ligation assay, to investigate 1204 endogenous PPIs in HeLa cells, and 557 PPIs of them tested positive</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/26206937" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:26206937
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:26206937" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with LRBA (P50851). LRBA is critical for CTLA4 trafficking; it protects CTLA4 from lysosomal degradation, enabling recycling to the cell surface. LRBA deficiency phenocopies CTLA4 haploinsufficiency (PMID:26206937). The deep research report (CTLA4-deep-research-falcon.md) confirms LRBA deficiency increases lysosomal degradation of CTLA4. This is a functionally important interaction but &#34;protein binding&#34; is still uninformative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The CTLA4-LRBA interaction is biologically significant for CTLA4 trafficking and stability. However, &#34;protein binding&#34; does not capture this functional relationship. A more informative annotation would describe the trafficking role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/26206937" target="_blank" class="term-link">
                                        PMID:26206937
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">LRBA colocalized with CTLA4 in endosomal vesicles and that LRBA deficiency or knockdown increased CTLA4 turnover, which resulted in reduced levels of CTLA4 protein in FoxP3(+) regulatory and activated conventional T cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:32296183" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with TMEM218 (A2RU14), MALL (Q13021), and CTXN3 (Q4LDR2). PMID:32296183 is a reference map of the human binary protein interactome (HuRI). High-throughput yeast two-hybrid. These are not well-characterized interactions for CTLA4 and may represent false positives or non-core interactions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> High-throughput IPI data. Interactions with TMEM218, MALL, and CTXN3 are not well-characterized for CTLA4 function. &#34;Protein binding&#34; is uninformative and these interactions lack follow-up validation in the context of CTLA4 biology.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                                        PMID:32296183
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">HI-III-20 (Human Interactome obtained from screening Space III, published in 2020), contains 52,569 verified PPIs involving 8,275 proteins</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32822567" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32822567
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A Human IgSF Cell-Surface Interactome Reveals a Complex Netw...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:32822567" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD80 (P33681) and CD86 (P42081). PMID:32822567 is a human IgSF cell-surface interactome study. Confirms known CTLA4-B7 interactions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. These are well-established interactions captured by more specific MF annotations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32822567" target="_blank" class="term-link">
                                        PMID:32822567
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We executed an interactome screen of 564 human cell-surface and secreted proteins, most of which are immunoglobulin superfamily (IgSF) proteins, using a high-throughput, automated ELISA-based screening platform</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:33961781
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Dual proteome-scale networks reveal cell-specific remodeling...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:33961781" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with LRBA (P50851). Dual proteome-scale network study confirming CTLA4-LRBA interaction. Biologically significant but &#34;protein binding&#34; is uninformative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The CTLA4-LRBA interaction is important for CTLA4 stability and trafficking but &#34;protein binding&#34; does not capture this.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                                        PMID:33961781
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/35922511" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:35922511
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A physical wiring diagram for the human immune system.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:35922511" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with CD80 (P33681) and CD86 (P42081). PMID:35922511 is a physical wiring diagram for the human immune system. Confirms known CTLA4-B7 interactions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. These well-established interactions are captured by more specific MF terms.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/35922511" target="_blank" class="term-link">
                                        PMID:35922511
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">using a high-throughput surface receptor screening method, we systematically mapped the direct protein interactions across a recombinant library that encompasses most of the surface proteins that are detectable on human leukocytes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/40205054" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:40205054
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Multimodal cell maps as a foundation for structural and func...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:40205054" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with LRBA (P50851). Multimodal cell maps study. Confirms CTLA4-LRBA interaction.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. CTLA4-LRBA interaction is functionally significant for trafficking but not captured by this generic term.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/40205054" target="_blank" class="term-link">
                                        PMID:40205054
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Multimodal cell maps as a foundation for structural and functional genomics</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/7807015" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:7807015
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    CTLA-4 binding to the lipid kinase phosphatidylinositol 3-ki...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:7807015" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with PIK3R1 (P27986, the p85 subunit of PI3K). CTLA4 cytoplasmic tail YVKM motif, when phosphorylated, recruits PI3K p85 subunit. This is a known signaling interaction downstream of CTLA4. However, &#34;protein binding&#34; does not capture this signaling relationship.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The CTLA4-PI3K interaction via the phosphorylated YVKM motif is functionally important for downstream signaling, but &#34;protein binding&#34; is uninformative. The interaction is better described in the context of signaling pathway annotations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/7807015" target="_blank" class="term-link">
                                        PMID:7807015
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CTLA-4 can also associate with PI 3-kinase as detected by lipid kinase analysis and immunoblotting with anti-p85 antiserum</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/9398332" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:9398332
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:9398332" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with PIK3R1 (P27986). Further evidence for the CTLA4-PI3K p85 interaction. Same reasoning as above.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; is uninformative. The CTLA4-PI3K p85 interaction is real but better described functionally.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9398332" target="_blank" class="term-link">
                                        PMID:9398332
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">we demonstrate association of the mu2 subunit of AP-2, the clathrin-associated complex found in plasma membrane-associated coated pits, with the cytoplasmic tail of CTLA-4, but not CD28</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/9813138" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:9813138
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005515" data-r="PMID:9813138" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI for protein binding with PIK3R1 (P27986). PMID:9813138 (Schneider et al. 1998) showed that Rlk/Txk phosphorylates the YVKM motif and regulates PI3K binding to CTLA4. Provides mechanistic detail about the CTLA4-PI3K interaction.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While mechanistically informative, &#34;protein binding&#34; does not capture the functional significance. The interaction is real and well-characterized but the GO term is uninformative.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/9813138" target="_blank" class="term-link">
                                        PMID:9813138
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042130" target="_blank" class="term-link">
                                    GO:0042130
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell proliferation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0042130" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from Ensembl Compara ortholog transfer. CTLA4 is a well-established negative regulator of T cell proliferation. This is a core function of the protein.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function of CTLA4. It attenuates T cell activation and proliferation by competing with CD28 for B7 ligand binding and delivering inhibitory signals. Supported by extensive literature and more specific experimental annotations already present (negative regulation of T cell activation, negative regulation of TCR signaling).
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0140319" target="_blank" class="term-link">
                                    GO:0140319
                                </a>
                            </span>
                            <span class="term-label">receptor decoy activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279501
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural basis for co-stimulation by the human CTLA-4/B7-2...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0140319" data-r="PMID:11279501" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for receptor decoy activity based on the CTLA4/B7-2 crystal structure (Schwartz et al. 2001). CTLA4 binds CD80 and CD86 with higher avidity than CD28, effectively sequestering these ligands and preventing CD28-mediated co-stimulation. UniProt explicitly describes CTLA4 as acting as a decoy receptor. The GO term definition -- &#34;Binding and sequestering a specific receptor ligand to prevent it from binding to its regular receptor&#34; -- accurately describes CTLA4 function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core molecular function of CTLA4. It competitively binds B7 ligands (CD80/CD86) with higher affinity than CD28, sequestering them from the stimulatory receptor. Structural evidence from crystal structures directly supports this.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Regulation of T-cell activity is dependent on antigen-independent co-stimulatory signals provided by the disulphide-linked homodimeric T-cell surface receptors, CD28 and CTLA-4 ... subsequent engagement of CTLA-4 with these same ligands results in attenuation of the response</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0140319" target="_blank" class="term-link">
                                    GO:0140319
                                </a>
                            </span>
                            <span class="term-label">receptor decoy activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279502
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Crystal structure of the B7-1/CTLA-4 complex that inhibits h...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0140319" data-r="PMID:11279502" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for receptor decoy activity based on the CTLA4/B7-1 crystal structure (Stamper et al. 2001). Demonstrates that CTLA4 forms a zipper-like array with B7-1, creating stable signaling complexes at the T cell surface that sequester B7 ligands.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core molecular function. The crystal structure of CTLA4/B7-1 complex demonstrates the structural basis for ligand sequestration. The zipper-like oligomerization provides a mechanism for potent inhibitory signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                        PMID:11279502
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CTLA-4 and B7-1 pack in a strikingly periodic arrangement in which bivalent CTLA-4 homodimers bridge bivalent B7-1 homodimers. This zipper-like oligomerization provides the structural basis for forming unusually stable signalling complexes at the T-cell surface</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050868" target="_blank" class="term-link">
                                    GO:0050868
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell activation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279501
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural basis for co-stimulation by the human CTLA-4/B7-2...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050868" data-r="PMID:11279501" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for negative regulation of T cell activation. PMID:11279501 demonstrates through structural analysis that CTLA4 competitively binds B7 ligands to attenuate T cell responses. This is a core biological process function of CTLA4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function. CTLA4 is the canonical negative regulator of T cell activation. The structural evidence demonstrates how CTLA4-B7 interactions provide the basis for inhibiting CD28-dependent T cell activation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">subsequent engagement of CTLA-4 with these same ligands results in attenuation of the response</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050868" target="_blank" class="term-link">
                                    GO:0050868
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell activation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279502
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Crystal structure of the B7-1/CTLA-4 complex that inhibits h...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050868" data-r="PMID:11279502" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for negative regulation of T cell activation from the CTLA4/B7-1 crystal structure study. The zipper-like oligomerization of CTLA4 and B7-1 provides potent inhibitory signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function. Same core function as above, supported by complementary structural evidence from the B7-1 complex.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                        PMID:11279502
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">underscoring the importance of potent inhibitory signalling in human immune responses</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050868" target="_blank" class="term-link">
                                    GO:0050868
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell activation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:17875758
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050868" data-r="PMID:17875758" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for negative regulation of T cell activation based on PMID:17875758, which studied CTLA4 expression in B-CLL. This paper primarily examined gene expression profiles in CLL, not direct T cell activation experiments. The paper found CTLA4 overexpression associated with good clinical outcome in B-CLL, but this is indirect evidence for T cell regulation. However, CTLA4 as a negative regulator of T cell activation is overwhelmingly supported by other evidence (PMID:11279501, PMID:11279502, CTLA4-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The annotation of CTLA4 to negative regulation of T cell activation is correct and represents a core function of CTLA4, even though this particular reference (PMID:17875758) provides only indirect evidence from CLL gene expression profiling. The function is strongly validated by structural studies (PMID:11279501, PMID:11279502) and extensive literature on CTLA4 as an immune checkpoint.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                                        PMID:17875758
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the overexpression of CTLA4 and MNDA was associated with good outcome</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050860" target="_blank" class="term-link">
                                    GO:0050860
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279501
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural basis for co-stimulation by the human CTLA-4/B7-2...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050860" data-r="PMID:11279501" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for negative regulation of TCR signaling pathway. CTLA4 attenuates TCR signaling by competitively binding B7 ligands (PMID:11279501). The structural data shows how CTLA4/B7-2 network formation at the immunological synapse provides a mechanism for inhibiting TCR co-stimulation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function. CTLA4 directly modulates TCR signaling output by competing with CD28 for B7 ligand binding, as demonstrated by the crystal structure.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">provides a model for the periodic organization of these molecules within the immunological synapse and suggests a distinct mechanism for signalling by dimeric cell-surface receptors</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050860" target="_blank" class="term-link">
                                    GO:0050860
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279502
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Crystal structure of the B7-1/CTLA-4 complex that inhibits h...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050860" data-r="PMID:11279502" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for negative regulation of TCR signaling based on the CTLA4/B7-1 crystal structure. The formation of stable CTLA4-B7-1 complexes directly inhibits CD28-mediated co-stimulation of TCR signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function. Same reasoning as above; structural evidence demonstrates the mechanism for inhibiting TCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                        PMID:11279502
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CTLA-4 signalling attenuates it ... underscoring the importance of potent inhibitory signalling in human immune responses</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-388829
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="Reactome:R-HSA-388829" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome pathway &#34;SHP2 phosphatase binds CTLA-4&#34; (R-HSA-388829). CTLA4 is at the plasma membrane where SHP-2 binds to its cytoplasmic tail. Well-supported.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization. CTLA4 is a plasma membrane protein. Reactome annotation is consistent with extensive experimental evidence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-388833
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="Reactome:R-HSA-388833" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome pathway &#34;Phosphorylation of CTLA-4&#34; (R-HSA-388833). CTLA4 is phosphorylated at the plasma membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization. Consistent with other evidence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/28484017" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:28484017
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural basis for cancer immunotherapy by the first-in-cl...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="PMID:28484017" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP for plasma membrane localization based on PMID:28484017 (Ramagopal et al. 2017). This study determined the crystal structure of ipilimumab bound to CTLA4 and performed cell-based binding assays with CTLA4 mutants, demonstrating CTLA4 expression at the cell surface (plasma membrane). Mutagenesis of surface residues affected B7 ligand binding.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The cell-based binding assays using CTLA4 mutants confirm plasma membrane localization and surface expression.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/28484017" target="_blank" class="term-link">
                                        PMID:28484017
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The crystallographically observed binding interface was confirmed by a comprehensive cell-based binding assay against a library of CTLA-4 mutants</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0098636" target="_blank" class="term-link">
                                    GO:0098636
                                </a>
                            </span>
                            <span class="term-label">protein complex involved in cell adhesion</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/7544393" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:7544393
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of residues in the V domain of CD80 (B7-1) im...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0098636" data-r="PMID:7544393" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for protein complex involved in cell adhesion. PMID:7544393 (Fargeas et al. 1995) identified residues in the V domain of CD80 implicated in functional interactions with CD28 and CTLA4. CTLA4 does form complexes with B7 ligands at the cell surface in the immunological synapse, which could be considered cell adhesion-like. However, CTLA4 is fundamentally a signaling receptor rather than an adhesion molecule; its primary function is signal modulation rather than physical cell-cell adhesion.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While CTLA4/B7 interactions occur at the T cell-APC interface, calling this &#34;cell adhesion&#34; is a stretch. CTLA4 functions primarily in signaling modulation rather than adhesion. The annotation may reflect CTLA4&#39;s participation in the immunological synapse, but the GO term is misleading for this protein&#39;s core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/7544393" target="_blank" class="term-link">
                                        PMID:7544393
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Two hydrophobic residues in the V-like domain of CD80 were identified as critical for binding to CD28 and are also important for the interaction with CTLA4</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-388809
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="Reactome:R-HSA-388809" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome pathway &#34;CTLA-4 binds B7-1/B7-2&#34; (R-HSA-388809). CTLA4 binds B7 ligands at the plasma membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization consistent with all other evidence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-389532
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="Reactome:R-HSA-389532" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome pathway &#34;PP2A binds CTLA4 dimer&#34; (R-HSA-389532). PP2A interacts with CTLA4 at the plasma membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct localization consistent with all other evidence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8877421
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="Reactome:R-HSA-8877421" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome pathway &#34;CTLA4 gene expression is stimulated by FOXP3 and inhibited by RUNX1&#34; (R-HSA-8877421). This Reactome entry describes transcriptional regulation of CTLA4 by FOXP3 in Tregs.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct. CTLA4 protein is ultimately targeted to the plasma membrane. The Reactome annotation reflects CTLA4 as a membrane protein in the context of Treg biology.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006974" target="_blank" class="term-link">
                                    GO:0006974
                                </a>
                            </span>
                            <span class="term-label">DNA damage response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:17875758
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0006974" data-r="PMID:17875758" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP for DNA damage response based on PMID:17875758. This paper studied gene expression in CD38-high vs CD38-low B-CLL. The study found CTLA4 was differentially expressed and also examined ATM (a DNA damage response gene). However, the paper&#39;s focus was on gene expression profiling in CLL, and CTLA4 itself is not known to have a direct role in DNA damage response. The association appears to be correlative rather than functional. CTLA4 is not a DNA damage response gene -- it is an immune checkpoint receptor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CTLA4 is not a DNA damage response protein. PMID:17875758 studied gene expression profiles in B-CLL and examined ATM alongside CTLA4, but did not demonstrate a direct role for CTLA4 in DNA damage response. This appears to be an over-interpretation of a gene expression study. CTLA4 has no known molecular role in DNA damage sensing, signaling, or repair. The deep research report (CTLA4-deep-research-falcon.md) describes CTLA4 exclusively as an immune checkpoint receptor with no mention of DNA damage function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                                        PMID:17875758
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Gene expression analysis identified 76 differentially expressed genes in CD38 high versus low groups. Out of these genes, HEM1, CTLA4, and MNDA were selected for further studies</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030889" target="_blank" class="term-link">
                                    GO:0030889
                                </a>
                            </span>
                            <span class="term-label">negative regulation of B cell proliferation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:17875758
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0030889" data-r="PMID:17875758" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP for negative regulation of B cell proliferation. PMID:17875758 found CTLA4 overexpression was associated with good outcome in B-CLL (characterized by lower proliferative burden), and low CD38 CLL. However, this is a correlative observation from expression profiling rather than a direct functional assay showing CTLA4 negatively regulates B cell proliferation. CTLA4 is primarily a T cell receptor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence from PMID:17875758 is correlative gene expression data from CLL, not a direct demonstration that CTLA4 negatively regulates B cell proliferation. While CTLA4 expression has been reported on some B cells, and its overexpression correlates with better outcomes in B-CLL, this does not establish a direct mechanistic role in B cell proliferation regulation. CTLA4&#39;s primary function is T cell co-inhibition.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                                        PMID:17875758
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the overexpression of CTLA4 and MNDA was associated with good outcome</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043065" target="_blank" class="term-link">
                                    GO:0043065
                                </a>
                            </span>
                            <span class="term-label">positive regulation of apoptotic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:17875758
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0043065" data-r="PMID:17875758" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP for positive regulation of apoptotic process. PMID:17875758 studied gene expression in B-CLL. The paper found CTLA4 overexpression associated with good clinical outcomes, which could imply pro-apoptotic effects in CLL cells, but this is a correlative association from expression profiling, not a direct apoptosis assay.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence from PMID:17875758 is correlative. CTLA4 is not a direct positive regulator of apoptosis. While CTLA4 signaling in T cells can lead to T cell anergy (which is distinct from apoptosis), and CTLA4 expression in CLL correlates with better outcomes, this does not establish a direct pro-apoptotic molecular function for CTLA4.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                                        PMID:17875758
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">the overexpression of CTLA4 and MNDA was associated with good outcome ... genes that may be involved in cell proliferation and survival</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050853" target="_blank" class="term-link">
                                    GO:0050853
                                </a>
                            </span>
                            <span class="term-label">B cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:17875758
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressin...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0050853" data-r="PMID:17875758" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP for B cell receptor signaling pathway. PMID:17875758 studied CTLA4 expression in B-CLL cells, which have constitutive BCR signaling. However, the paper demonstrates differential CTLA4 expression in CLL, not a direct role of CTLA4 in BCR signaling. CTLA4 is a co-inhibitory receptor for TCR signaling, not BCR signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PMID:17875758 is a gene expression study in B-CLL that does not demonstrate a mechanistic role for CTLA4 in BCR signaling. CTLA4 is expressed on some B cells but its primary signaling role is in T cells (TCR/CD28 pathway).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                                        PMID:17875758
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Gene expression analysis identified 76 differentially expressed genes in CD38 high versus low groups</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005794" target="_blank" class="term-link">
                                    GO:0005794
                                </a>
                            </span>
                            <span class="term-label">Golgi apparatus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15814706
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Exocytosis of CTLA-4 is dependent on phospholipase D and ADP...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005794" data-r="PMID:15814706" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for Golgi apparatus localization. PMID:15814706 (Mead et al. 2005) showed that exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1, and is stimulated during activation of regulatory T cells. CTLA4 is known to traffic through the Golgi during biosynthesis and recycling. UniProt notes that CTLA4 exists primarily as an intracellular antigen with regulated trafficking. The deep research report (CTLA4-deep-research-falcon.md) confirms CTLA4 resides largely in intracellular vesicles at steady state.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CTLA4 is a transmembrane glycoprotein that undergoes N-glycosylation (Asn-113, Asn-145) and traffics through the Golgi as part of its biosynthetic and recycling pathways. The annotation is consistent with known CTLA4 trafficking biology.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link">
                                        PMID:15814706
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CTLA-4 was identified in a perinuclear compartment overlapping with the cis-Golgi marker GM-130 but did not colocalize strongly with lysosomal markers such as CD63 and lysosome-associated membrane protein</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009897" target="_blank" class="term-link">
                                    GO:0009897
                                </a>
                            </span>
                            <span class="term-label">external side of plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18641304
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Acquisition of suppressive function by activated human CD4+ ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0009897" data-r="PMID:18641304" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for external side of plasma membrane. PMID:18641304 (Zheng et al. 2008) showed that activated CD4+CD25- T cells express CTLA4 on their surface and acquire suppressive function. Flow cytometry detection of surface CTLA4 demonstrates external plasma membrane localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Direct experimental evidence for surface expression of CTLA4, detected by flow cytometry on activated T cells.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link">
                                        PMID:18641304
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045334" target="_blank" class="term-link">
                                    GO:0045334
                                </a>
                            </span>
                            <span class="term-label">clathrin-coated endocytic vesicle</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15814706
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Exocytosis of CTLA-4 is dependent on phospholipase D and ADP...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0045334" data-r="PMID:15814706" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for clathrin-coated endocytic vesicle localization. CTLA4 is known to undergo constitutive clathrin-mediated endocytosis. Its cytoplasmic YVKM motif interacts with the AP-2 adaptor complex, and phosphorylation at Tyr-201 regulates this interaction (PMID:9175836). PMID:15814706 (Mead et al. 2005) studied CTLA4 exocytosis and trafficking in regulatory T cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> CTLA4 is constitutively endocytosed via clathrin-mediated endocytosis. The YVKM motif in the cytoplasmic tail binds AP-2, and its localization in clathrin-coated vesicles is well-established. This annotation is consistent with known CTLA4 trafficking biology.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link">
                                        PMID:15814706
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">expression of CTLA-4 at the plasma membrane (PM) is controlled by exocytosis of CTLA-4-containing vesicles and followed by rapid endocytosis</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045590" target="_blank" class="term-link">
                                    GO:0045590
                                </a>
                            </span>
                            <span class="term-label">negative regulation of regulatory T cell differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18641304
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Acquisition of suppressive function by activated human CD4+ ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0045590" data-r="PMID:18641304" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for negative regulation of Treg differentiation. PMID:18641304 showed that CTLA4 expression (rather than FoxP3) is associated with acquisition of suppressive function by activated CD4+CD25- T cells, suggesting CTLA4 modulates the threshold for Treg-like function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Consistent with the IBA annotation for the same term. PMID:18641304 provides direct evidence that CTLA4 expression modulates T cell suppressive function and Treg differentiation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link">
                                        PMID:18641304
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0048471" target="_blank" class="term-link">
                                    GO:0048471
                                </a>
                            </span>
                            <span class="term-label">perinuclear region of cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15814706
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Exocytosis of CTLA-4 is dependent on phospholipase D and ADP...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0048471" data-r="PMID:15814706" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA for perinuclear region of cytoplasm localization. CTLA4 is known to accumulate in intracellular compartments, including the perinuclear region, at steady state due to constitutive endocytosis. UniProt notes CTLA4 &#34;exists primarily as an intracellular antigen.&#34; PMID:15814706 (Mead et al. 2005) demonstrated CTLA4 trafficking and subcellular distribution in T cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Consistent with known CTLA4 cell biology. At steady state, the majority of CTLA4 resides intracellularly in perinuclear vesicular compartments, with rapid endocytosis maintaining low surface expression.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link">
                                        PMID:15814706
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">CTLA-4 was identified in a perinuclear compartment overlapping with the cis-Golgi marker GM-130</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/3220103" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:3220103
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human Ig superfamily CTLA-4 gene chromosomal localization an...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0005886" data-r="PMID:3220103" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS for plasma membrane localization from PMID:3220103 (Dariavach et al. 1988). This is the original paper that identified CTLA4 as a human Ig superfamily member and determined its chromosomal location. The sequence predicts a transmembrane protein localized to the plasma membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The original characterization paper identifying CTLA4 as a membrane protein. Consistent with all subsequent experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/3220103" target="_blank" class="term-link">
                                        PMID:3220103
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The first exon encodes a V-like domain of 116 amino acids, the second one a hydrophobic putative transmembrane region of 37 amino acids and the third one a 34 amino acid putative cytoplasmic domain</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006955" target="_blank" class="term-link">
                                    GO:0006955
                                </a>
                            </span>
                            <span class="term-label">immune response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/3220103" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:3220103
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human Ig superfamily CTLA-4 gene chromosomal localization an...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0006955" data-r="PMID:3220103" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS for immune response from PMID:3220103. The original characterization paper identifies CTLA4 as an Ig superfamily member expressed in lymphocytes, implying immune function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Broad but correct. CTLA4 is clearly involved in immune response. More specific terms provide detail.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/3220103" target="_blank" class="term-link">
                                        PMID:3220103
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The mouse CTLA-4 gene has been shown to code for an activated lymphocyte-associated sequence belonging to the Ig gene superfamily</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030547" target="_blank" class="term-link">
                                    GO:0030547
                                </a>
                            </span>
                            <span class="term-label">signaling receptor inhibitor activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:11279501
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structural basis for co-stimulation by the human CTLA-4/B7-2...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="P16410" data-a="GO:0030547" data-r="PMID:11279501" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> CTLA4 functions as an inhibitor of CD28 signaling receptor activity by competitively binding B7 ligands (CD80/CD86) with higher avidity, preventing CD28 from receiving co-stimulatory signals. This is a core molecular function. GO:0030547 is defined as &#34;Binds to and modulates the activity of a signaling receptor&#34; -- CTLA4 modulates CD28 activity by sequestering its ligands.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This molecular function term more accurately describes how CTLA4 functionally inhibits CD28 signaling. While receptor decoy activity (GO:0140319) captures the ligand sequestration, signaling receptor inhibitor activity captures the functional consequence on CD28. Together these provide a more complete picture of CTLA4 molecular function than the generic &#34;protein binding&#34; annotations currently in place.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                        PMID:11279501
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Engagement of CD28 with B7-1 and B7-2 ligands on antigen-presenting cells (APCs) provides a stimulatory signal for T-cell activation, whereas subsequent engagement of CTLA-4 with these same ligands results in attenuation of the response</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                        PMID:11279502
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Signalling through CD28 augments the T-cell response, whereas CTLA-4 signalling attenuates it</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>CTLA4 acts as a decoy receptor by binding B7 ligands (CD80/B7-1 and CD86/B7-2) on antigen-presenting cells with higher avidity than the co-stimulatory receptor CD28, thereby sequestering these ligands and preventing CD28-mediated co-stimulation of T cells. This competitive inhibition is the primary molecular function of CTLA4, resulting in negative regulation of T cell activation and TCR signaling.</h3>
                <span class="vote-buttons" data-g="P16410" data-a="FUNCTION: CTLA4 acts as a decoy receptor by binding B7 ligan..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0140319" target="_blank" class="term-link">
                            receptor decoy activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050868" target="_blank" class="term-link">
                                negative regulation of T cell activation
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050860" target="_blank" class="term-link">
                                negative regulation of T cell receptor signaling pathway
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009897" target="_blank" class="term-link">
                                external side of plasma membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                                PMID:11279501
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">the 3.2-A resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                                PMID:11279502
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">This zipper-like oligomerization provides the structural basis for forming unusually stable signalling complexes at the T-cell surface, underscoring the importance of potent inhibitory signalling in human immune responses</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000117.md" target="_blank" class="term-link">
                            GO_REF:0000117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Electronic Gene Ontology annotations created by ARBA machine learning models</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/3220103" target="_blank" class="term-link">
                            PMID:3220103
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Human Ig superfamily CTLA-4 gene chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Original characterization of human CTLA4 as an Ig superfamily member on chromosome 2.</div>
                        
                        <div class="finding-text">"Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/7544393" target="_blank" class="term-link">
                            PMID:7544393
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Identified CD80 residues important for binding CD28 and CTLA4.</div>
                        
                        <div class="finding-text">"Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/7807015" target="_blank" class="term-link">
                            PMID:7807015
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Demonstrated interaction between CTLA4 cytoplasmic tail and PI3K p85 subunit.</div>
                        
                        <div class="finding-text">"CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9175836" target="_blank" class="term-link">
                            PMID:9175836
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Phosphorylation of Tyr-201 in YVKM motif prevents AP-2 binding and blocks endocytosis.</div>
                        
                        <div class="finding-text">"Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9398332" target="_blank" class="term-link">
                            PMID:9398332
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Further evidence for CTLA4-PI3K p85 interaction and clathrin-associated protein binding.</div>
                        
                        <div class="finding-text">"Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9813138" target="_blank" class="term-link">
                            PMID:9813138
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Rlk/Txk phosphorylates CTLA4 YVKM motif, regulating PI3K binding.</div>
                        
                        <div class="finding-text">"Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11279501" target="_blank" class="term-link">
                            PMID:11279501
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">3.2A crystal structure of CTLA4/B7-2 complex reveals bivalent network formation at the immunological synapse, providing structural basis for CTLA4 inhibitory function.</div>
                        
                        <div class="finding-text">"the 3.2-A resolution structure of the complex between the disulphide-linked homodimer of human CTLA-4 and the receptor-binding domain of human B7-2"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11279502" target="_blank" class="term-link">
                            PMID:11279502
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">3.0A crystal structure of CTLA4/B7-1 complex reveals zipper-like oligomerization forming stable inhibitory signaling complexes.</div>
                        
                        <div class="finding-text">"CTLA-4 and B7-1 pack in a strikingly periodic arrangement in which bivalent CTLA-4 homodimers bridge bivalent B7-1 homodimers"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15814706" target="_blank" class="term-link">
                            PMID:15814706
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">CTLA4 localizes to Golgi, clathrin-coated vesicles, and perinuclear region; exocytosis is PLD and ARF1 dependent.</div>
                        
                        <div class="finding-text">"Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16551244" target="_blank" class="term-link">
                            PMID:16551244
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A molecular perspective of CTLA-4 function.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Comprehensive review of CTLA4 molecular function, trafficking, and signaling.</div>
                        
                        <div class="finding-text">"A molecular perspective of CTLA-4 function"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/17875758" target="_blank" class="term-link">
                            PMID:17875758
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Gene expression profiling in B-CLL identified CTLA4 overexpression associated with good clinical outcome in CD38-low CLL. Study is correlative rather than mechanistic.</div>
                        
                        <div class="finding-text">"the overexpression of CTLA4 and MNDA was associated with good outcome"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18468488" target="_blank" class="term-link">
                            PMID:18468488
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">CTLA-4 trafficking and surface expression.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Review of CTLA4 constitutive endocytosis, recycling, and regulated surface expression.</div>
                        
                        <div class="finding-text">"CTLA-4 trafficking and surface expression"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18641304" target="_blank" class="term-link">
                            PMID:18641304
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">CTLA4 expression, not FoxP3, associated with acquisition of suppressive function by activated CD4+CD25- T cells. Surface CTLA4 detected by flow cytometry.</div>
                        
                        <div class="finding-text">"Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20587542" target="_blank" class="term-link">
                            PMID:20587542
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4-CD80 interaction.</div>
                        
                        <div class="finding-text">"PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21982860" target="_blank" class="term-link">
                            PMID:21982860
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A secreted protein microarray platform for extracellular protein interaction discovery.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4 interactions with CD80 and CD86.</div>
                        
                        <div class="finding-text">"A secreted protein microarray platform for extracellular protein interaction discovery"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25241761" target="_blank" class="term-link">
                            PMID:25241761
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4-CD86 interaction by proximity ligation assay.</div>
                        
                        <div class="finding-text">"Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26206937" target="_blank" class="term-link">
                            PMID:26206937
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Demonstrated CTLA4-LRBA interaction important for CTLA4 trafficking and stability.</div>
                        
                        <div class="finding-text">"Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28484017" target="_blank" class="term-link">
                            PMID:28484017
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">3.0A crystal structure of ipilimumab bound to CTLA4 shows steric overlap with B7 ligand binding site. Cell-based mutant binding assays confirm surface expression and interaction determinants.</div>
                        
                        <div class="finding-text">"The crystallographically observed binding interface was confirmed by a comprehensive cell-based binding assay against a library of CTLA-4 mutants"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">High-throughput binary interactome mapping detecting CTLA4 interactions.</div>
                        
                        <div class="finding-text">"A reference map of the human binary protein interactome"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32822567" target="_blank" class="term-link">
                            PMID:32822567
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein Interactions.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4-CD80 and CTLA4-CD86 interactions.</div>
                        
                        <div class="finding-text">"A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein Interactions"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33961781" target="_blank" class="term-link">
                            PMID:33961781
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4-LRBA interaction.</div>
                        
                        <div class="finding-text">"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35922511" target="_blank" class="term-link">
                            PMID:35922511
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A physical wiring diagram for the human immune system.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4-CD80 and CTLA4-CD86 interactions.</div>
                        
                        <div class="finding-text">"A physical wiring diagram for the human immune system"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/40205054" target="_blank" class="term-link">
                            PMID:40205054
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Multimodal cell maps as a foundation for structural and functional genomics.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Confirmed CTLA4-LRBA interaction.</div>
                        
                        <div class="finding-text">"Multimodal cell maps as a foundation for structural and functional genomics"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-388809
                        
                    </span>
                </div>
                
                <div class="reference-title">CTLA-4 binds B7-1/B7-2</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-388829
                        
                    </span>
                </div>
                
                <div class="reference-title">SHP2 phosphatase binds CTLA-4</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-388833
                        
                    </span>
                </div>
                
                <div class="reference-title">Phosphorylation of CTLA-4</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-389532
                        
                    </span>
                </div>
                
                <div class="reference-title">PP2A binds CTLA4 dimer</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-8877421
                        
                    </span>
                </div>
                
                <div class="reference-title">CTLA4 gene expression is stimulated by FOXP3 and inhibited by RUNX1</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/CTLA4/CTLA4-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research report on CTLA4 function, trafficking, and clinical applications.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">CTLA4 is a canonical Ig-superfamily inhibitory receptor that enforces early checkpoint control of T-cell priming via high-avidity binding to CD80/CD86 and Treg-mediated trans-endocytosis of these ligands.</div>
                        
                        <div class="finding-text">"CTLA-4 inhibits T-cell activation primarily by binding CD80/CD86 with higher avidity than CD28, thereby limiting signal 2 co-stimulation and inducing tolerance/anergy at the priming phase in lymphoid tissues"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(CTLA4-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="P16410" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2026-02-14T14:18:05.048310'<br />
end_time: '2026-02-14T14:24:25.932738'<br />
duration_seconds: 380.88<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: CTLA4<br />
  gene_symbol: CTLA4<br />
  uniprot_accession: P16410<br />
  protein_description: 'RecName: Full=Cytotoxic T-lymphocyte protein 4; AltName: Full=Cytotoxic<br />
    T-lymphocyte-associated antigen 4; Short=CTLA-4; AltName: CD_antigen=CD152; Flags:<br />
    Precursor;'<br />
  gene_info: Name=CTLA4; Synonyms=CD152;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: CTLA4. (IPR008096); CTLA4/CD28. (IPR040216); Ig-like_dom_sf. (IPR036179);<br />
    Ig-like_fold. (IPR013783); Ig_sub. (IPR003599)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 26</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> P16410</li>
<li><strong>Protein Description:</strong> RecName: Full=Cytotoxic T-lymphocyte protein 4; AltName: Full=Cytotoxic T-lymphocyte-associated antigen 4; Short=CTLA-4; AltName: CD_antigen=CD152; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=CTLA4; Synonyms=CD152;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> CTLA4. (IPR008096); CTLA4/CD28. (IPR040216); Ig-like_dom_sf. (IPR036179); Ig-like_fold. (IPR013783); Ig_sub. (IPR003599)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "CTLA4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'CTLA4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>CTLA4</strong> (gene ID: CTLA4, UniProt: P16410) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> P16410</li>
<li><strong>Protein Description:</strong> RecName: Full=Cytotoxic T-lymphocyte protein 4; AltName: Full=Cytotoxic T-lymphocyte-associated antigen 4; Short=CTLA-4; AltName: CD_antigen=CD152; Flags: Precursor;</li>
<li><strong>Gene Information:</strong> Name=CTLA4; Synonyms=CD152;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> CTLA4. (IPR008096); CTLA4/CD28. (IPR040216); Ig-like_dom_sf. (IPR036179); Ig-like_fold. (IPR013783); Ig_sub. (IPR003599)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "CTLA4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'CTLA4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>CTLA4</strong> (gene ID: CTLA4, UniProt: P16410) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan and verification<br />
- Identity check: The target is human CTLA4 (UniProt P16410), encoding cytotoxic T-lymphocyte antigen 4 (CTLA‚Äë4/CD152), an immunoglobulin superfamily receptor with an Ig-like V-set extracellular domain, a transmembrane region, and a short cytoplasmic tail. The gene symbol CTLA4 matches the protein description; the organism is Homo sapiens; and the domain architecture (Ig-like fold) aligns with literature that treats CTLA‚Äë4 as an Ig superfamily receptor regulating CD80/CD86‚ÄìCD28 co‚Äëstimulation (review context) (jamal2024dendriticcelland pages 7-9, tsilifis2023toomuchof pages 8-9).</p>
<p>Comprehensive research report<br />
1) Key concepts and definitions<br />
- Molecular identity and domains: CTLA‚Äë4 is an inhibitory co‚Äëreceptor on T cells with an extracellular Ig-like V-set domain that binds B7 ligands CD80 (B7‚Äë1) and CD86 (B7‚Äë2), outcompeting CD28; a transmembrane helix; and a cytoplasmic tail that regulates endocytosis/trafficking. It is constitutively expressed by regulatory T cells (Tregs) and induced on activated conventional T cells (expert reviews) (https://doi.org/10.37349/ei.2024.00136, Apr 2024) (jamal2024dendriticcelland pages 7-9); (https://doi.org/10.3389/fimmu.2023.1279201, Oct 2023) (tsilifis2023toomuchof pages 8-9).<br />
- Mechanism of action: CTLA‚Äë4 inhibits T‚Äëcell activation primarily by binding CD80/CD86 with higher avidity than CD28, thereby limiting ‚Äúsignal 2‚Äù co‚Äëstimulation and inducing tolerance/anergy at the priming phase in lymphoid tissues (review) (jamal2024dendriticcelland pages 7-9). In Tregs, CTLA‚Äë4 mediates suppression of antigen‚Äëpresenting cells (APCs) by removing CD80/CD86 from dendritic cells via trans‚Äëendocytosis/trogocytosis and by limiting DC maturation; surface CTLA‚Äë4 is dynamically regulated by rapid endocytosis and recycling (mechanistic preprint and PIRD review) (https://doi.org/10.1101/2023.12.01.569613, Dec 2023) (jamison2023anil2mutein pages 28-31); (https://doi.org/10.3389/fimmu.2023.1279201, Oct 2023) (tsilifis2023toomuchof pages 8-9).<br />
- Cellular and subcellular localization/regulation: CTLA‚Äë4 resides largely in intracellular vesicles at steady state due to constitutive clathrin‚Äëmediated endocytosis; recycling to the surface (e.g., after TCR stimulation) is regulated by LRBA and Rab11 pathways. DEF6 mutations impair Rab11‚Äëmediated CTLA‚Äë4 trafficking; LRBA deficiency increases lysosomal degradation of CTLA‚Äë4, reducing its surface availability (mechanistic review and cohort analyses) (jamison2023anil2mutein pages 28-31, donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6, tsilifis2023toomuchof pages 8-9).<br />
- Role in Treg biology: FoxP3+ Tregs constitutively express high CTLA‚Äë4 and use it, together with IL‚Äë10, to restrict DC costimulation (down‚Äëmodulating CD80/CD86 and MHC‚ÄëII), enforcing peripheral tolerance. An IL‚Äë2 mutein that preferentially expands Tregs increased IL‚Äë10 and CTLA‚Äë4‚Äëdependent suppression of DCs, functionally enhancing CTLA‚Äë4‚Äìmediated control (mechanistic advance) (jamison2023anil2mutein pages 28-31).</p>
<p>2) Recent developments and latest research (2023‚Äì2024 prioritized)<br />
- CTLA‚Äë4 pathway genetics and modifiers: Recent reviews and cohorts reaffirm CTLA‚Äë4 haploinsufficiency as a Tregopathy presenting with variable autoimmunity, lymphoproliferation, and hypogammaglobulinemia; overlapping LRBA deficiency reflects LRBA‚Äôs role in protecting CTLA‚Äë4 from lysosomal degradation; DEF6 affects CTLA‚Äë4 recycling (review, Oct 2023) (tsilifis2023toomuchof pages 8-9). A 2024‚Äì2025 stream of case/series reports further illustrate variant heterogeneity and phenotype breadth, including neurologic and hematologic autoimmunity, and discuss targeted therapy with abatacept (Frontiers in Immunology, Nov 2025; DOI: https://doi.org/10.3389/fimmu.2025.1665184) (chen2025anovelctla4 pages 9-9) and a 2025 J Clin Immunol report on a pathogenic ligand‚Äëbinding‚Äëregion variant (https://doi.org/10.1007/s10875-025-01960-5) (sormani2025anewvariant pages 1-2).<br />
- Treg‚Äëcentric mechanistic advance: An Fc‚Äëfused IL‚Äë2 mutein expanded activated Tregs with high CTLA‚Äë4 and IL‚Äë10, limiting DC maturation (reduced MHC‚ÄëII upregulation) and promoting CTLA‚Äë4‚Äìdependent trans‚Äëendocytosis of CD80/CD86; in NOD mice this induced T‚Äëcell anergy and controlled local inflammation (bioRxiv, Dec 2023) (https://doi.org/10.1101/2023.12.01.569613) (jamison2023anil2mutein pages 28-31).<br />
- LRBA deficiency and abatacept: A 2024 longitudinal cohort of LRBA‚Äëdeficient patients showed profoundly reduced Helios+ natural/na√Øve Tregs at baseline, with significant increases and clinical improvement during abatacept (CTLA‚Äë4‚ÄëIg) therapy, supporting restoration of CTLA‚Äë4 pathway function (bioRxiv, Feb 2024; DOI: https://doi.org/10.1101/2024.02.10.579765) (donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6, donhauser2024abatacepttreatmentin pages 12-15).<br />
- CTLA‚Äë4 blockade in oncology‚ÄîHCC: A 2024 peer‚Äëreviewed synthesis details 48‚Äëmonth updates of the phase 3 HIMALAYA trial of the STRIDE regimen (single priming dose tremelimumab + durvalumab q4w) in unresectable/advanced HCC, confirming sustained OS benefit and characterizing immune‚Äëmediated toxicities (Targeted Oncology, Jan 2024; https://doi.org/10.1007/s11523-023-01026-9) (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8).<br />
- Real‚Äëworld STRIDE outcomes: A 2023‚Äì2024 multicenter Japanese cohort (n=120) reported objective response and safety of durvalumab+tremelimumab in practice, with predictors of discontinuation highlighting hepatic function and age (Oncology Letters, Jun 2024; https://doi.org/10.3892/ol.2024.14530) (shimose2024initialclinicalexperience pages 1-2).</p>
<p>3) Current applications and real‚Äëworld implementations<br />
- Immune checkpoint inhibition‚Äîcancer care<br />
  ‚Ä¢ Tremelimumab (anti‚ÄëCTLA‚Äë4) within STRIDE for unresectable/advanced HCC: Phase 3 HIMALAYA demonstrated median OS 16.43 months for STRIDE vs 13.77 with sorafenib (HR 0.78, 96.02% CI 0.65‚Äì0.93); 36‚Äëmonth OS 30.7% vs 20.2%. ORR 20.1% vs 5.1% with sorafenib; median PFS was similar (3.78 vs 4.07 months). Benefits persisted at 48 months, and health‚Äëstate/QOL outcomes favored STRIDE. Immune‚Äëmediated AEs were more frequent with STRIDE, but grade 3‚Äì4 TRAEs and discontinuations were not higher than sorafenib in some analyses (Targeted Oncology review, Jan 2024) (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8). URLs: https://doi.org/10.1007/s11523-023-01026-9 (published Jan 2024).<br />
  ‚Ä¢ Real‚Äëworld Durvalumab+Tremelimumab (STRIDE‚Äëlike) in HCC: In 120 patients treated Mar 2023‚ÄìJan 2024, ORR 15.8%, DCR 53.3%, median PFS 3.9 months; any‚Äëgrade AEs 83.3%, grade ‚â•3 AEs 36.7%, with liver injury most frequent. First‚Äëline use had higher DCR than later lines (65.8% vs 45.9%) (Oncology Letters, Jun 2024). URL: https://doi.org/10.3892/ol.2024.14530 (shimose2024initialclinicalexperience pages 1-2).<br />
- Co‚Äëstimulation blockade‚Äîautoimmunity and transplantation<br />
  ‚Ä¢ Abatacept (CTLA‚Äë4‚ÄëIg): Approved for multiple autoimmune indications; binds CD80/CD86 to block CD28 co‚Äëstimulation, inducing tolerance. A 2024 review summarizes mechanism, benefits, and next‚Äëgeneration CTLA‚Äë4‚ÄëIg variants with higher CD80/86 affinity and longer half‚Äëlife; belatacept (higher CD86/CD80 affinity) is highlighted in kidney transplantation (Exploration of Immunology, Apr 2024; https://doi.org/10.37349/ei.2024.00136) (jamal2024dendriticcelland pages 7-9). In LRBA deficiency, abatacept increased circulating FoxP3+Helios+ natural Tregs and improved clinical measures in a 2024 longitudinal cohort (https://doi.org/10.1101/2024.02.10.579765) (donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6, donhauser2024abatacepttreatmentin pages 12-15).</p>
<p>4) Expert opinions and analysis from authoritative sources (2023‚Äì2024)<br />
- PIRD/Tregopathy consensus framing: A 2023 Frontiers in Immunology review outlines CTLA‚Äë4 haploinsufficiency, LRBA and DEF6 as a mechanistic spectrum of Tregopathies, emphasizing variable immunophenotypes and shared pathophysiology via CTLA‚Äë4 trafficking and surface expression (Oct 2023) (https://doi.org/10.3389/fimmu.2023.1279201) (tsilifis2023toomuchof pages 8-9).<br />
- Dendritic cell/co‚Äëstimulation targeting in autoimmunity: A 2024 review synthesizes strategies to induce antigen‚Äëspecific tolerance and pharmacologic CD80/86 blockade, highlighting clinical experience with abatacept/belatacept and investigational enhanced CTLA‚Äë4‚ÄëIg constructs (Apr 2024) (https://doi.org/10.37349/ei.2024.00136) (jamal2024dendriticcelland pages 7-9).<br />
- HCC immunotherapy perspective: A 2024 tremelimumab review synthesizes HIMALAYA efficacy, long‚Äëterm OS maintenance, safety, health‚Äërelated quality‚Äëof‚Äëlife outcomes, and comparative evidence versus atezolizumab+bevacizumab (Jan 2024) (https://doi.org/10.1007/s11523-023-01026-9) (france2024tremelimumabareview pages 7-8, france2024tremelimumabareview pages 4-5).</p>
<p>5) Relevant statistics and data from recent studies<br />
- HIMALAYA (STRIDE) key outcomes (advanced/unresectable HCC):<br />
  ‚Ä¢ Median OS 16.43 months with STRIDE vs 13.77 with sorafenib (HR 0.78, 96.02% CI 0.65‚Äì0.93); 36‚Äëmonth OS 30.7% vs 20.2%; ORR 20.1% vs 5.1%; median DOR 22.34 months; PFS ~3.78 vs 4.07 months; piecewise HR 0.87 (0‚Äì9 mo) and 0.70 (&gt;9 mo). Immune‚Äëmediated AEs with STRIDE ~34.5%; grade 3‚Äì4 TRAEs ~25.8%; TRAE‚Äërelated deaths ~2.3% (Targeted Oncology review, Jan 2024; includes 48‚Äëmonth update) (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8). URL: https://doi.org/10.1007/s11523-023-01026-9.<br />
- Real‚Äëworld Dur/Tre (Japan, 120 patients, 2023‚Äì2024): ORR 15.8%, DCR 53.3%; median PFS 3.9 months; any‚Äëgrade AEs 83.3%, grade ‚â•3 AEs 36.7%; first‚Äëline DCR 65.8% vs 45.9% later‚Äëline; liver injury most frequent AE; poor liver function and age predicted AE‚Äëdriven discontinuation (Oncology Letters, Jun 2024). URL: https://doi.org/10.3892/ol.2024.14530 (shimose2024initialclinicalexperience pages 1-2).<br />
- Co‚Äëstimulation blockade pharmacology: Belatacept exhibits stronger binding to CD86 (~4√ó) and CD80 (~2√ó) relative to abatacept, aligning with its potency in transplant settings; newer CTLA‚Äë4‚ÄëIg variants aim for higher avidity and prolonged exposure (Exploration of Immunology, Apr 2024). URL: https://doi.org/10.37349/ei.2024.00136 (jamal2024dendriticcelland pages 7-9).<br />
- Treg mechanistic modulation (preclinical, 2023): IL‚Äë2 mutein expanded CTLA‚Äë4hi, IL‚Äë10hi Tregs that suppressed DCs by CTLA‚Äë4‚Äìdependent trans‚Äëendocytosis of CD80/CD86 and limited MHC‚ÄëII upregulation; promoted T‚Äëcell anergy in NOD mice (bioRxiv Dec 2023). URL: https://doi.org/10.1101/2023.12.01.569613 (jamison2023anil2mutein pages 28-31).<br />
- LRBA deficiency clinical immunology (2024): Marked baseline reductions in Helios+ natural and na√Øve Tregs with recovery toward age‚Äëmatched norms under abatacept; improved disease activity indices and sIL‚Äë2R reductions in many patients; some proceeded to allo‚ÄëHSCT for durable remission (bioRxiv Feb 2024). URL: https://doi.org/10.1101/2024.02.10.579765 (donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6, donhauser2024abatacepttreatmentin pages 12-15).</p>
<p>Therapeutic implications and pathway placement<br />
- CTLA‚Äë4 functions at the priming phase by setting the CD80/86‚ÄìCD28 activation threshold on APCs. In cancer, anti‚ÄëCTLA‚Äë4 antibodies (tremelimumab, ipilimumab) release this brake, augmenting T‚Äëcell priming and diversification; STRIDE demonstrates survival benefit in HCC with manageable immune‚Äëmediated toxicity (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8). In autoimmunity and Tregopathies (CTLA4 haploinsufficiency, LRBA deficiency), CTLA‚Äë4 insufficiency promotes unchecked co‚Äëstimulation; co‚Äëstimulation blockade with CTLA‚Äë4‚ÄëIg (abatacept) restores tolerance mechanisms and improves immunologic/clinical parameters (jamal2024dendriticcelland pages 7-9, donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6, tsilifis2023toomuchof pages 8-9).</p>
<p>Notes on evidence strength and gaps<br />
- Several mechanistic insights (IL‚Äë2 mutein/Treg augmentation) are preclinical or preprint and should be validated clinically (jamison2023anil2mutein pages 28-31). Genetic cohort details and variant reports in 2025 extend 2023‚Äì2024 themes but are post‚Äë2024; they substantiate heterogeneity and targeted therapy rationale (chen2025anovelctla4 pages 9-9, sormani2025anewvariant pages 1-2). Oncology efficacy statistics for HIMALAYA/STRIDE are from peer‚Äëreviewed 2024 synthesis of a pivotal phase 3 trial and are robust (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8). Real‚Äëworld HCC Dur/Tre data (Japan) provide external validity with expected safety patterns in cirrhotic populations (shimose2024initialclinicalexperience pages 1-2). Co‚Äëstimulation‚Äëtargeting reviews summarize approved agents and next‚Äëgen constructs (jamal2024dendriticcelland pages 7-9).</p>
<p>Cited sources (URLs and dates)<br />
- France NL, Blair HA. Tremelimumab: A Review in Advanced or Unresectable HCC. Targeted Oncology. Jan 2024. URL: https://doi.org/10.1007/s11523-023-01026-9 (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8).<br />
- Shimose S, et al. Real‚Äëworld Durvalumab+Tremelimumab in u‚ÄëHCC. Oncology Letters. Jun 2024. URL: https://doi.org/10.3892/ol.2024.14530 (shimose2024initialclinicalexperience pages 1-2).<br />
- Jamal M, Shibli F. Dendritic cell and co‚Äëstimulatory molecule targeted therapy for autoimmune diseases. Exploration of Immunology. Apr 2024. URL: https://doi.org/10.37349/ei.2024.00136 (jamal2024dendriticcelland pages 7-9).<br />
- Tsilifis C, Slatter MA, Gennery AR. Primary immune regulatory disorders review (includes CTLA‚Äë4/LRBA/DEF6). Frontiers in Immunology. Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1279201 (tsilifis2023toomuchof pages 8-9).<br />
- Jamison BL, et al. IL‚Äë2 mutein increases IL‚Äë10 and CTLA‚Äë4‚Äëdependent suppression by Tregs. bioRxiv. Dec 2023. URL: https://doi.org/10.1101/2023.12.01.569613 (jamison2023anil2mutein pages 28-31).<br />
- Donhauser S, et al. Abatacept in LRBA deficiency increases FoxP3+Helios+ natural Tregs. bioRxiv. Feb 2024. URL: https://doi.org/10.1101/2024.02.10.579765 (donhauser2024abatacepttreatmentin pages 12-15, donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6).<br />
- Chen F, et al. Novel CTLA‚Äë4 deletion variant; refractory AIHA; targeted therapy context. Frontiers in Immunology. Nov 2025. URL: https://doi.org/10.3389/fimmu.2025.1665184 (chen2025anovelctla4 pages 9-9).<br />
- Sormani J, et al. New CTLA4 variant; heterogeneous phenotypes. Journal of Clinical Immunology. Nov 2025. URL: https://doi.org/10.1007/s10875-025-01960-5 (sormani2025anewvariant pages 1-2).</p>
<p>Conclusion<br />
CTLA‚Äë4 (human CTLA4, UniProt P16410) is a canonical Ig‚Äësuperfamily inhibitory receptor that enforces early checkpoint control of T‚Äëcell priming via high‚Äëavidity binding to CD80/CD86 and Treg‚Äëmediated trans‚Äëendocytosis of these ligands. Its biology is tightly regulated by intracellular trafficking machinery (LRBA, Rab11; modulated by DEF6), with insufficiency causing a Tregopathy marked by autoimmunity and lymphoproliferation. Therapeutically, anti‚ÄëCTLA‚Äë4 antibodies improve survival in selected cancers (e.g., HIMALAYA/STRIDE in HCC), while CTLA‚Äë4‚ÄëIg (abatacept/belatacept) leverages co‚Äëstimulation blockade to treat autoimmunity and prevent rejection. Emerging 2023‚Äì2024 data refine clinical efficacy/safety benchmarks in HCC and provide mechanistic avenues‚Äîsuch as IL‚Äë2 muteins‚Äîto potentiate CTLA‚Äë4‚Äìdependent Treg function. These advances collectively support precise, pathway‚Äëdirected use of CTLA‚Äë4 modulators across oncology, autoimmunity, and transplantation (france2024tremelimumabareview pages 4-5, france2024tremelimumabareview pages 7-8, shimose2024initialclinicalexperience pages 1-2, jamal2024dendriticcelland pages 7-9, tsilifis2023toomuchof pages 8-9, jamison2023anil2mutein pages 28-31, donhauser2024abatacepttreatmentin pages 8-12, donhauser2024abatacepttreatmentin pages 1-6).</p>
<p>References</p>
<ol>
<li>
<p>(jamal2024dendriticcelland pages 7-9): Mazen El Jamal and Farah Shibli. Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies. Exploration of Immunology, pages 189-210, Apr 2024. URL: https://doi.org/10.37349/ei.2024.00136, doi:10.37349/ei.2024.00136. This article has 7 citations.</p>
</li>
<li>
<p>(tsilifis2023toomuchof pages 8-9): Christo Tsilifis, Mary A. Slatter, and Andrew R. Gennery. Too much of a good thing: a review of primary immune regulatory disorders. Frontiers in Immunology, Oct 2023. URL: https://doi.org/10.3389/fimmu.2023.1279201, doi:10.3389/fimmu.2023.1279201. This article has 18 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(jamison2023anil2mutein pages 28-31): Braxton L. Jamison, Matthew Lawrance, Chun Jing Wang, Hannah A. DeBerg, David M. Sansom, Marc A. Gavin, Lucy S.K. Walker, and Daniel J. Campbell. An il-2 mutein increases il-10 and ctla-4-dependent suppression of dendritic cells by regulatory t cells. bioRxiv, Dec 2023. URL: https://doi.org/10.1101/2023.12.01.569613, doi:10.1101/2023.12.01.569613. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(donhauser2024abatacepttreatmentin pages 8-12): Sabine Donhauser, Emilia Salzmann-Manrique, Leon Maximilian Lueck, Julia Fekadu-Siebald, Christoph K√∂nigs, Ralf Schubert, Celia Kaffenberger, Laura M. Moser, Peter Bader, Sabine Huenecke, and Shahrzad Bakhtiar. Abatacept treatment in lrba deficient patients results in an increase in circulating foxp3+helios+ natural treg. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2024.02.10.579765, doi:10.1101/2024.02.10.579765. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(donhauser2024abatacepttreatmentin pages 1-6): Sabine Donhauser, Emilia Salzmann-Manrique, Leon Maximilian Lueck, Julia Fekadu-Siebald, Christoph K√∂nigs, Ralf Schubert, Celia Kaffenberger, Laura M. Moser, Peter Bader, Sabine Huenecke, and Shahrzad Bakhtiar. Abatacept treatment in lrba deficient patients results in an increase in circulating foxp3+helios+ natural treg. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2024.02.10.579765, doi:10.1101/2024.02.10.579765. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(chen2025anovelctla4 pages 9-9): Feng Chen, Siyu Lei, Caihui Yuan, Zhongjin Xu, Qian Wan, Chongjun Wu, and Ting Xiong. A novel ctla-4 deletion variant in a child with refractory autoimmune hemolytic anemia: molecular and functional characterization. Frontiers in Immunology, Nov 2025. URL: https://doi.org/10.3389/fimmu.2025.1665184, doi:10.3389/fimmu.2025.1665184. This article has 0 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(sormani2025anewvariant pages 1-2): Jonathan Sormani, Alexandre Belot, Raphaele Nove-Josserand, Capucine Picard, J√©r√©mie Rosain, Marine Villard, Sebastien Viel, Marie Ouachee-Chardin, Emma Mercier, Catherine Giannoli, Philippe Moskovtchenko, Maud Rabeyrin, Brigitte Balme, Isabelle Durieu, Anne-Laure Mathieu, and Quitterie Reynaud. A new variant in ctla4 highlights the heterogeneous phenotype of ctla4 haploinsufficiency. Journal of Clinical Immunology, Nov 2025. URL: https://doi.org/10.1007/s10875-025-01960-5, doi:10.1007/s10875-025-01960-5. This article has 0 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(donhauser2024abatacepttreatmentin pages 12-15): Sabine Donhauser, Emilia Salzmann-Manrique, Leon Maximilian Lueck, Julia Fekadu-Siebald, Christoph K√∂nigs, Ralf Schubert, Celia Kaffenberger, Laura M. Moser, Peter Bader, Sabine Huenecke, and Shahrzad Bakhtiar. Abatacept treatment in lrba deficient patients results in an increase in circulating foxp3+helios+ natural treg. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2024.02.10.579765, doi:10.1101/2024.02.10.579765. This article has 0 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(france2024tremelimumabareview pages 4-5): Nicole L. France and Hannah A. Blair. Tremelimumab: a review in advanced or unresectable hepatocellular carcinoma. Targeted Oncology, 19:115-123, Jan 2024. URL: https://doi.org/10.1007/s11523-023-01026-9, doi:10.1007/s11523-023-01026-9. This article has 19 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(france2024tremelimumabareview pages 7-8): Nicole L. France and Hannah A. Blair. Tremelimumab: a review in advanced or unresectable hepatocellular carcinoma. Targeted Oncology, 19:115-123, Jan 2024. URL: https://doi.org/10.1007/s11523-023-01026-9, doi:10.1007/s11523-023-01026-9. This article has 19 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(shimose2024initialclinicalexperience pages 1-2): Shigeo Shimose, Issei Saeki, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Satoru Kakizaki, Takeshi Hatanaka, Kyo Sasaki, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Soji Nishina, Motoyuki Otsuka, Hiroki Kawashima, Tetsuji Takayama, Taro Takami, and Takumi Kawaguchi. Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‚Äëworld practice. Oncology Letters, Jun 2024. URL: https://doi.org/10.3892/ol.2024.14530, doi:10.3892/ol.2024.14530. This article has 19 citations and is from a peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>jamal2024dendriticcelland pages 7-9</li>
<li>tsilifis2023toomuchof pages 8-9</li>
<li>sormani2025anewvariant pages 1-2</li>
<li>shimose2024initialclinicalexperience pages 1-2</li>
<li>donhauser2024abatacepttreatmentin pages 8-12</li>
<li>donhauser2024abatacepttreatmentin pages 1-6</li>
<li>donhauser2024abatacepttreatmentin pages 12-15</li>
<li>france2024tremelimumabareview pages 4-5</li>
<li>france2024tremelimumabareview pages 7-8</li>
<li>https://doi.org/10.37349/ei.2024.00136,</li>
<li>https://doi.org/10.3389/fimmu.2023.1279201,</li>
<li>https://doi.org/10.1101/2023.12.01.569613,</li>
<li>https://doi.org/10.3389/fimmu.2025.1665184</li>
<li>https://doi.org/10.1007/s10875-025-01960-5</li>
<li>https://doi.org/10.1101/2023.12.01.569613</li>
<li>https://doi.org/10.1101/2024.02.10.579765</li>
<li>https://doi.org/10.1007/s11523-023-01026-9</li>
<li>https://doi.org/10.3892/ol.2024.14530</li>
<li>https://doi.org/10.37349/ei.2024.00136</li>
<li>https://doi.org/10.3389/fimmu.2023.1279201</li>
<li>https://doi.org/10.1007/s11523-023-01026-9.</li>
<li>https://doi.org/10.1101/2024.02.10.579765,</li>
<li>https://doi.org/10.3389/fimmu.2025.1665184,</li>
<li>https://doi.org/10.1007/s10875-025-01960-5,</li>
<li>https://doi.org/10.1007/s11523-023-01026-9,</li>
<li>https://doi.org/10.3892/ol.2024.14530,</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: P16410
gene_symbol: CTLA4
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  CTLA4 (cytotoxic T-lymphocyte-associated protein 4, CD152) encodes a type I transmembrane
  inhibitory co-receptor of the immunoglobulin superfamily. CTLA4 contains an extracellular
  Ig-like V-type domain that binds B7 family ligands CD80 (B7-1) and CD86 (B7-2) on
  antigen-presenting cells with higher avidity than the stimulatory co-receptor CD28, thereby
  competitively inhibiting T cell co-stimulation at the priming phase (PMID:11279501,
  PMID:11279502). CTLA4 functions as a disulfide-linked homodimer. Its surface expression
  is tightly regulated by constitutive clathrin-mediated endocytosis and recycling; at steady
  state it resides largely in intracellular vesicles (Golgi, endosomes, perinuclear region),
  with surface expression induced upon T cell activation. CTLA4 is constitutively expressed
  on FoxP3+ regulatory T cells (Tregs), where it mediates suppressive function including
  trans-endocytosis of CD80/CD86 from dendritic cells (CTLA4-deep-research-falcon.md). The
  cytoplasmic tail contains a YVKM motif whose phosphorylation at Tyr-201 by TXK and JAK2
  regulates AP-2 binding and endocytic trafficking. Haploinsufficiency causes IDAIL (immune
  dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation), and common
  variants confer susceptibility to type 1 diabetes, Graves disease, celiac disease, and SLE.
  Anti-CTLA4 antibodies (ipilimumab, tremelimumab) are used in cancer immunotherapy; CTLA4-Ig
  fusions (abatacept, belatacept) are used to treat autoimmunity and prevent transplant
  rejection.
alternative_products:
- name: &#39;1&#39;
  id: P16410-1
- name: 2 (ss-CTLA-4)
  id: P16410-2
  sequence_note: VSP_041284
- name: &#39;3&#39;
  id: P16410-3
  sequence_note: VSP_041284, VSP_041287
- name: &#39;4&#39;
  id: P16410-4
  sequence_note: VSP_041285, VSP_041286, VSP_041287
- name: &#39;5&#39;
  id: P16410-5
  sequence_note: VSP_047238, VSP_047239
existing_annotations:

# ============================================================
# IBA annotations (phylogenetically inferred)
# ============================================================

- term:
    id: GO:0009897
    label: external side of plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      CTLA4 is detected on the external side of the plasma membrane of T cells upon
      activation. IBA annotation is supported by phylogenetic inference from CTLA4 orthologs
      including mouse Ctla4 and human CD28. Multiple experimental studies confirm CTLA4
      surface expression, including flow cytometry studies (PMID:18641304) and structural
      studies showing the extracellular domain in complex with B7 ligands (PMID:11279501,
      PMID:11279502). UniProt notes CTLA4 is a cell membrane single-pass type I membrane
      protein with regulated surface expression. The deep research report
      (CTLA4-deep-research-falcon.md) confirms CTLA4 resides largely in intracellular
      vesicles at steady state with regulated surface expression.
    action: ACCEPT
    reason: &gt;-
      Well-supported localization. CTLA4 is a transmembrane receptor whose extracellular
      Ig-like domain binds B7 ligands on APCs at the cell surface. IBA annotation is
      consistent with direct experimental evidence from structural studies and flow
      cytometry.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        the 3.2-A resolution structure of the complex between the disulphide-linked
        homodimer of human CTLA-4 and the receptor-binding domain of human B7-2
    - reference_id: PMID:18641304
      supporting_text: &gt;-
        Acquisition of suppressive function by activated human CD4+ CD25- T cells is
        associated with the expression of CTLA-4

- term:
    id: GO:0045590
    label: negative regulation of regulatory T cell differentiation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      IBA annotation for negative regulation of Treg differentiation. CTLA4 is constitutively
      expressed on Tregs and plays complex roles in Treg biology. PMID:18641304 showed that
      activated CD4+CD25- T cells acquiring CTLA4 expression gain suppressive capacity,
      suggesting CTLA4 may regulate the threshold for Treg-like function. CTLA4 haploinsufficiency
      leads to dysregulated Treg function. However, CTLA4 is also required for Treg suppressive
      function, so its role in negatively regulating Treg differentiation is nuanced. The IBA
      annotation is phylogenetically supported and consistent with the IDA annotation from
      PMID:18641304.
    action: ACCEPT
    reason: &gt;-
      Phylogenetically supported by IBA and consistent with the experimental IDA annotation
      from PMID:18641304 already in the annotation set. CTLA4 engagement can modulate the
      balance of Treg differentiation.
    supported_by:
    - reference_id: PMID:18641304
      supporting_text: &gt;-
        Acquisition of suppressive function by activated human CD4+ CD25- T cells is
        associated with the expression of CTLA-4 not FoxP3

- term:
    id: GO:0050852
    label: T cell receptor signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      CTLA4 is a key modulator of T cell receptor signaling. It competes with CD28 for
      B7 ligand binding to attenuate TCR-dependent T cell activation (PMID:11279501,
      PMID:11279502). Phosphorylation of its cytoplasmic YVKM motif recruits PI3K and
      SHP-2 phosphatase, directly modulating TCR downstream signaling. IBA annotation
      is well-supported.
    action: ACCEPT
    reason: &gt;-
      CTLA4 is a central component of the TCR co-stimulatory signaling axis. Its engagement
      with B7 ligands directly modulates TCR signaling output. Phylogenetically conserved
      function supported by extensive literature.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        Regulation of T-cell activity is dependent on antigen-independent co-stimulatory
        signals provided by the disulphide-linked homodimeric T-cell surface receptors,
        CD28 and CTLA-4
    - reference_id: PMID:11279502
      supporting_text: &gt;-
        Signalling through CD28 augments the T-cell response, whereas CTLA-4 signalling
        attenuates it

- term:
    id: GO:0050853
    label: B cell receptor signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      IBA annotation for B cell receptor signaling pathway. CTLA4 is primarily a T cell
      receptor. PMID:17875758 reported CTLA4 expression in B-CLL cells and found CTLA4
      overexpression associated with good clinical outcome, but this study examined CTLA4
      as a differentially expressed gene in CLL cells rather than demonstrating a direct
      mechanistic role in BCR signaling. CTLA4 expression on B cells has been reported
      but is not a core function.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      CTLA4 is primarily a T cell co-inhibitory receptor. While expression on B cells has
      been reported (PMID:17875758), its primary evolved function is in T cell biology.
      CTLA4 does not have a well-established direct role in BCR signaling.
    supported_by:
    - reference_id: PMID:17875758
      supporting_text: &gt;-
        the overexpression of CTLA4 and MNDA was associated with good outcome

# ============================================================
# IEA annotations (electronic/computational)
# ============================================================

- term:
    id: GO:0002250
    label: adaptive immune response
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      IEA annotation from UniProt keyword mapping (KW-1064 Adaptive immunity). CTLA4 is
      a central regulator of adaptive immune responses, specifically T cell activation.
      This is a broad but accurate annotation.
    action: ACCEPT
    reason: &gt;-
      CTLA4 is unquestionably involved in adaptive immunity as a key checkpoint receptor
      on T cells. While broad, this term is accurate and appropriately captures the
      biological context. More specific annotations (negative regulation of T cell
      activation, etc.) are also present to provide detail.

- term:
    id: GO:0002376
    label: immune system process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      IEA from UniProt keyword mapping (KW-0391 Immunity). Very broad term. CTLA4 is
      clearly involved in immune system processes. More specific terms are already
      annotated.
    action: ACCEPT
    reason: &gt;-
      Very broad but correct. More informative child terms (adaptive immune response,
      negative regulation of T cell activation, etc.) are already annotated, making this
      redundant but not incorrect. Acceptable as an IEA.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &gt;-
      IEA from UniProt subcellular location vocabulary mapping. CTLA4 is a type I
      transmembrane protein localized to the plasma membrane. This is well-supported
      by UniProt annotation and multiple experimental studies.
    action: ACCEPT
    reason: &gt;-
      Correct localization. CTLA4 is a single-pass type I membrane protein confirmed
      at the plasma membrane by multiple structural and cell biological studies
      (PMID:11279501, PMID:11279502, PMID:28484017).

- term:
    id: GO:0006955
    label: immune response
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA from InterPro domain mapping (IPR008096 CTLA4). Broad but correct. CTLA4
      is a key immune regulator. More specific terms are present.
    action: ACCEPT
    reason: &gt;-
      Broad but accurate IEA. More specific terms provide the detail. The InterPro
      mapping from the CTLA4 domain correctly identifies immune function.

- term:
    id: GO:0009897
    label: external side of plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: &gt;-
      IEA from ARBA machine learning model. Consistent with the IBA annotation for
      the same term and experimental evidence from IDA (PMID:18641304). CTLA4 extracellular
      domain is exposed on the cell surface.
    action: ACCEPT
    reason: &gt;-
      Correct and consistent with other evidence sources (IBA and IDA annotations for
      the same term). CTLA4 extracellular domain binds B7 ligands at the cell surface.

- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA from InterPro domain mapping (IPR008096 CTLA4). Very broad CC term. CTLA4 is
      indeed a membrane protein. More specific terms (plasma membrane, external side of
      plasma membrane) are already annotated.
    action: ACCEPT
    reason: &gt;-
      Very broad but correct. CTLA4 is a transmembrane protein. More specific membrane
      localizations are captured by other annotations.

- term:
    id: GO:0042129
    label: regulation of T cell proliferation
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA from InterPro domain mapping (IPR040216 CTLA4/CD28). CTLA4 is a well-established
      negative regulator of T cell proliferation. The neutral &#34;regulation&#34; rather than
      &#34;negative regulation&#34; is acceptable for an IEA, though the more specific term
      GO:0042130 (negative regulation of T cell proliferation) is also present via Ensembl
      IEA transfer.
    action: ACCEPT
    reason: &gt;-
      Correct. CTLA4 is a major regulator (specifically negative regulator) of T cell
      proliferation. The broader &#34;regulation&#34; term is acceptable for an InterPro-derived
      IEA since the family includes both CD28 (positive) and CTLA4 (negative).

# ============================================================
# IPI annotations (protein-protein interaction evidence)
# All are &#34;protein binding&#34; - evaluate each
# ============================================================

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11279501
  review:
    summary: &gt;-
      IPI for protein binding with CD86 (P42081). PMID:11279501 (Schwartz et al. 2001)
      determined the 3.2A crystal structure of the CTLA4/B7-2 (CD86) complex, providing
      direct structural evidence for this interaction. This is a core functional interaction
      for CTLA4. The term &#34;protein binding&#34; is uninformative; the interaction with CD86 is
      better captured by the receptor decoy activity annotation (GO:0140319).
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      While the physical interaction is real and well-documented by crystal structure, the
      term &#34;protein binding&#34; (GO:0005515) is uninformative per GO curation guidelines. The
      functional significance of this interaction is better captured by receptor decoy
      activity (GO:0140319) and signaling receptor inhibitor activity. The IPI annotation
      is a consequence of IntAct import and adds little beyond what is captured by more
      specific MF terms.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        the 3.2-A resolution structure of the complex between the disulphide-linked
        homodimer of human CTLA-4 and the receptor-binding domain of human B7-2

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11279502
  review:
    summary: &gt;-
      IPI for protein binding with CD80 (P33681). PMID:11279502 (Stamper et al. 2001)
      determined the 3.0A crystal structure of the CTLA4/B7-1 (CD80) complex. Core
      functional interaction, but &#34;protein binding&#34; is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      Same reasoning as the CTLA4-CD86 interaction. The physical interaction is real but
      &#34;protein binding&#34; is uninformative. Functional significance captured by receptor
      decoy activity (GO:0140319).
    supported_by:
    - reference_id: PMID:11279502
      supporting_text: &gt;-
        the crystal structure of the human CTLA-4/B7-1 co-stimulatory complex at 3.0 A
        resolution

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20587542
  review:
    summary: &gt;-
      IPI for protein binding with CD80 (P33681). PMID:20587542 (Ghiotto et al. 2010)
      is primarily a study of PD-L1 and PD-L2 interaction mechanisms with PD-1 but also
      detected CTLA4-CD80 interaction. The CTLA4-CD80 interaction is well-established
      by structural studies.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. The CTLA4-CD80 interaction is well-established
      and functionally captured by receptor decoy activity (GO:0140319).
    supported_by:
    - reference_id: PMID:20587542
      supporting_text: &gt;-
        PD-L1 behaved in a similar manner with its second ligand, CD80 [study also
        detected CTLA4 interactions with CD80]

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:21982860
  review:
    summary: &gt;-
      IPI for protein binding with CD80 (P33681) and CD86 (P42081). PMID:21982860 is a
      secreted protein microarray platform study. High-throughput detection of known
      interactions.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. CTLA4 interactions with CD80 and CD86 are
      well-documented by structural studies and are functionally captured by more specific
      MF terms.
    supported_by:
    - reference_id: PMID:21982860
      supporting_text: &gt;-
        we screened a set of 89 immunoglobulin (Ig)-type receptors against a highly
        diverse extracellular protein microarray with 686 genes represented

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25241761
  review:
    summary: &gt;-
      IPI for protein binding with CD86 (P42081). PMID:25241761 used in situ proximity
      ligation assay (PLA) to systematically profile protein-protein interactions. Confirms
      the known CTLA4-CD86 interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. The CTLA4-CD86 interaction is functionally
      captured by receptor decoy activity and other specific terms.
    supported_by:
    - reference_id: PMID:25241761
      supporting_text: &gt;-
        Herein, we collected ‚àº 700 primary antibodies and employed a highly sensitive
        and specific technique, an in situ proximity ligation assay, to investigate 1204
        endogenous PPIs in HeLa cells, and 557 PPIs of them tested positive

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:26206937
  review:
    summary: &gt;-
      IPI for protein binding with LRBA (P50851). LRBA is critical for CTLA4 trafficking;
      it protects CTLA4 from lysosomal degradation, enabling recycling to the cell surface.
      LRBA deficiency phenocopies CTLA4 haploinsufficiency (PMID:26206937). The deep research
      report (CTLA4-deep-research-falcon.md) confirms LRBA deficiency increases lysosomal
      degradation of CTLA4. This is a functionally important interaction but &#34;protein binding&#34;
      is still uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      The CTLA4-LRBA interaction is biologically significant for CTLA4 trafficking and
      stability. However, &#34;protein binding&#34; does not capture this functional relationship.
      A more informative annotation would describe the trafficking role.
    supported_by:
    - reference_id: PMID:26206937
      supporting_text: &gt;-
        LRBA colocalized with CTLA4 in endosomal vesicles and that LRBA deficiency or
        knockdown increased CTLA4 turnover, which resulted in reduced levels of CTLA4
        protein in FoxP3(+) regulatory and activated conventional T cells

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: &gt;-
      IPI for protein binding with TMEM218 (A2RU14), MALL (Q13021), and CTXN3 (Q4LDR2).
      PMID:32296183 is a reference map of the human binary protein interactome (HuRI).
      High-throughput yeast two-hybrid. These are not well-characterized interactions for
      CTLA4 and may represent false positives or non-core interactions.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      High-throughput IPI data. Interactions with TMEM218, MALL, and CTXN3 are not
      well-characterized for CTLA4 function. &#34;Protein binding&#34; is uninformative and these
      interactions lack follow-up validation in the context of CTLA4 biology.
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: &gt;-
        HI-III-20 (Human Interactome obtained from screening Space III, published in
        2020), contains 52,569 verified PPIs involving 8,275 proteins

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32822567
  review:
    summary: &gt;-
      IPI for protein binding with CD80 (P33681) and CD86 (P42081). PMID:32822567 is a
      human IgSF cell-surface interactome study. Confirms known CTLA4-B7 interactions.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. These are well-established interactions captured
      by more specific MF annotations.
    supported_by:
    - reference_id: PMID:32822567
      supporting_text: &gt;-
        We executed an interactome screen of 564 human cell-surface and secreted
        proteins, most of which are immunoglobulin superfamily (IgSF) proteins, using a
        high-throughput, automated ELISA-based screening platform

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: &gt;-
      IPI for protein binding with LRBA (P50851). Dual proteome-scale network study
      confirming CTLA4-LRBA interaction. Biologically significant but &#34;protein binding&#34;
      is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      The CTLA4-LRBA interaction is important for CTLA4 stability and trafficking but
      &#34;protein binding&#34; does not capture this.
    supported_by:
    - reference_id: PMID:33961781
      supporting_text: &gt;-
        Through affinity-purification mass spectrometry, we have created two
        proteome-scale, cell-line-specific interaction networks

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:35922511
  review:
    summary: &gt;-
      IPI for protein binding with CD80 (P33681) and CD86 (P42081). PMID:35922511 is a
      physical wiring diagram for the human immune system. Confirms known CTLA4-B7 interactions.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. These well-established interactions are captured
      by more specific MF terms.
    supported_by:
    - reference_id: PMID:35922511
      supporting_text: &gt;-
        using a high-throughput surface receptor screening method, we systematically
        mapped the direct protein interactions across a recombinant library that
        encompasses most of the surface proteins that are detectable on human leukocytes

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:40205054
  review:
    summary: &gt;-
      IPI for protein binding with LRBA (P50851). Multimodal cell maps study. Confirms
      CTLA4-LRBA interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. CTLA4-LRBA interaction is functionally significant
      for trafficking but not captured by this generic term.
    supported_by:
    - reference_id: PMID:40205054
      supporting_text: &gt;-
        Multimodal cell maps as a foundation for structural and functional genomics

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:7807015
  review:
    summary: &gt;-
      IPI for protein binding with PIK3R1 (P27986, the p85 subunit of PI3K). CTLA4
      cytoplasmic tail YVKM motif, when phosphorylated, recruits PI3K p85 subunit. This
      is a known signaling interaction downstream of CTLA4. However, &#34;protein binding&#34;
      does not capture this signaling relationship.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      The CTLA4-PI3K interaction via the phosphorylated YVKM motif is functionally
      important for downstream signaling, but &#34;protein binding&#34; is uninformative. The
      interaction is better described in the context of signaling pathway annotations.
    supported_by:
    - reference_id: PMID:7807015
      supporting_text: &gt;-
        CTLA-4 can also associate with PI 3-kinase as detected by lipid kinase analysis
        and immunoblotting with anti-p85 antiserum

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9398332
  review:
    summary: &gt;-
      IPI for protein binding with PIK3R1 (P27986). Further evidence for the CTLA4-PI3K
      p85 interaction. Same reasoning as above.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      &#34;Protein binding&#34; is uninformative. The CTLA4-PI3K p85 interaction is real but
      better described functionally.
    supported_by:
    - reference_id: PMID:9398332
      supporting_text: &gt;-
        we demonstrate association of the mu2 subunit of AP-2, the clathrin-associated
        complex found in plasma membrane-associated coated pits, with the cytoplasmic
        tail of CTLA-4, but not CD28

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:9813138
  review:
    summary: &gt;-
      IPI for protein binding with PIK3R1 (P27986). PMID:9813138 (Schneider et al. 1998)
      showed that Rlk/Txk phosphorylates the YVKM motif and regulates PI3K binding to
      CTLA4. Provides mechanistic detail about the CTLA4-PI3K interaction.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      While mechanistically informative, &#34;protein binding&#34; does not capture the functional
      significance. The interaction is real and well-characterized but the GO term is
      uninformative.
    supported_by:
    - reference_id: PMID:9813138
      supporting_text: &gt;-
        Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates
        PI 3-kinase binding to T-cell antigen CTLA-4

# ============================================================
# IEA: negative regulation of T cell proliferation (Ensembl)
# ============================================================

- term:
    id: GO:0042130
    label: negative regulation of T cell proliferation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      IEA from Ensembl Compara ortholog transfer. CTLA4 is a well-established negative
      regulator of T cell proliferation. This is a core function of the protein.
    action: ACCEPT
    reason: &gt;-
      Core function of CTLA4. It attenuates T cell activation and proliferation by
      competing with CD28 for B7 ligand binding and delivering inhibitory signals.
      Supported by extensive literature and more specific experimental annotations
      already present (negative regulation of T cell activation, negative regulation
      of TCR signaling).

# ============================================================
# IDA annotations (direct assay evidence)
# ============================================================

- term:
    id: GO:0140319
    label: receptor decoy activity
  evidence_type: IDA
  original_reference_id: PMID:11279501
  review:
    summary: &gt;-
      IDA for receptor decoy activity based on the CTLA4/B7-2 crystal structure
      (Schwartz et al. 2001). CTLA4 binds CD80 and CD86 with higher avidity than CD28,
      effectively sequestering these ligands and preventing CD28-mediated co-stimulation.
      UniProt explicitly describes CTLA4 as acting as a decoy receptor. The GO term
      definition -- &#34;Binding and sequestering a specific receptor ligand to prevent it
      from binding to its regular receptor&#34; -- accurately describes CTLA4 function.
    action: ACCEPT
    reason: &gt;-
      Core molecular function of CTLA4. It competitively binds B7 ligands (CD80/CD86)
      with higher affinity than CD28, sequestering them from the stimulatory receptor.
      Structural evidence from crystal structures directly supports this.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        Regulation of T-cell activity is dependent on antigen-independent co-stimulatory
        signals provided by the disulphide-linked homodimeric T-cell surface receptors,
        CD28 and CTLA-4 ... subsequent engagement of CTLA-4 with these same ligands
        results in attenuation of the response

- term:
    id: GO:0140319
    label: receptor decoy activity
  evidence_type: IDA
  original_reference_id: PMID:11279502
  review:
    summary: &gt;-
      IDA for receptor decoy activity based on the CTLA4/B7-1 crystal structure
      (Stamper et al. 2001). Demonstrates that CTLA4 forms a zipper-like array with B7-1,
      creating stable signaling complexes at the T cell surface that sequester B7 ligands.
    action: ACCEPT
    reason: &gt;-
      Core molecular function. The crystal structure of CTLA4/B7-1 complex demonstrates
      the structural basis for ligand sequestration. The zipper-like oligomerization provides
      a mechanism for potent inhibitory signaling.
    supported_by:
    - reference_id: PMID:11279502
      supporting_text: &gt;-
        CTLA-4 and B7-1 pack in a strikingly periodic arrangement in which bivalent
        CTLA-4 homodimers bridge bivalent B7-1 homodimers. This zipper-like oligomerization
        provides the structural basis for forming unusually stable signalling complexes at
        the T-cell surface

- term:
    id: GO:0050868
    label: negative regulation of T cell activation
  evidence_type: IDA
  original_reference_id: PMID:11279501
  review:
    summary: &gt;-
      IDA for negative regulation of T cell activation. PMID:11279501 demonstrates through
      structural analysis that CTLA4 competitively binds B7 ligands to attenuate T cell
      responses. This is a core biological process function of CTLA4.
    action: ACCEPT
    reason: &gt;-
      Core function. CTLA4 is the canonical negative regulator of T cell activation. The
      structural evidence demonstrates how CTLA4-B7 interactions provide the basis for
      inhibiting CD28-dependent T cell activation.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        subsequent engagement of CTLA-4 with these same ligands results in attenuation
        of the response

- term:
    id: GO:0050868
    label: negative regulation of T cell activation
  evidence_type: IDA
  original_reference_id: PMID:11279502
  review:
    summary: &gt;-
      IDA for negative regulation of T cell activation from the CTLA4/B7-1 crystal
      structure study. The zipper-like oligomerization of CTLA4 and B7-1 provides
      potent inhibitory signaling.
    action: ACCEPT
    reason: &gt;-
      Core function. Same core function as above, supported by complementary structural
      evidence from the B7-1 complex.
    supported_by:
    - reference_id: PMID:11279502
      supporting_text: &gt;-
        underscoring the importance of potent inhibitory signalling in human immune responses

- term:
    id: GO:0050868
    label: negative regulation of T cell activation
  evidence_type: IDA
  original_reference_id: PMID:17875758
  review:
    summary: &gt;-
      IDA for negative regulation of T cell activation based on PMID:17875758, which
      studied CTLA4 expression in B-CLL. This paper primarily examined gene expression
      profiles in CLL, not direct T cell activation experiments. The paper found CTLA4
      overexpression associated with good clinical outcome in B-CLL, but this is indirect
      evidence for T cell regulation. However, CTLA4 as a negative regulator of T cell
      activation is overwhelmingly supported by other evidence (PMID:11279501,
      PMID:11279502, CTLA4-deep-research-falcon.md).
    action: ACCEPT
    reason: &gt;-
      The annotation of CTLA4 to negative regulation of T cell activation is correct and
      represents a core function of CTLA4, even though this particular reference
      (PMID:17875758) provides only indirect evidence from CLL gene expression profiling.
      The function is strongly validated by structural studies (PMID:11279501, PMID:11279502)
      and extensive literature on CTLA4 as an immune checkpoint.
    supported_by:
    - reference_id: PMID:17875758
      supporting_text: &gt;-
        the overexpression of CTLA4 and MNDA was associated with good outcome

- term:
    id: GO:0050860
    label: negative regulation of T cell receptor signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:11279501
  review:
    summary: &gt;-
      IDA for negative regulation of TCR signaling pathway. CTLA4 attenuates TCR
      signaling by competitively binding B7 ligands (PMID:11279501). The structural
      data shows how CTLA4/B7-2 network formation at the immunological synapse provides
      a mechanism for inhibiting TCR co-stimulation.
    action: ACCEPT
    reason: &gt;-
      Core function. CTLA4 directly modulates TCR signaling output by competing with
      CD28 for B7 ligand binding, as demonstrated by the crystal structure.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        provides a model for the periodic organization of these molecules within the
        immunological synapse and suggests a distinct mechanism for signalling by
        dimeric cell-surface receptors

- term:
    id: GO:0050860
    label: negative regulation of T cell receptor signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:11279502
  review:
    summary: &gt;-
      IDA for negative regulation of TCR signaling based on the CTLA4/B7-1 crystal
      structure. The formation of stable CTLA4-B7-1 complexes directly inhibits
      CD28-mediated co-stimulation of TCR signaling.
    action: ACCEPT
    reason: &gt;-
      Core function. Same reasoning as above; structural evidence demonstrates the
      mechanism for inhibiting TCR signaling.
    supported_by:
    - reference_id: PMID:11279502
      supporting_text: &gt;-
        CTLA-4 signalling attenuates it ... underscoring the importance of potent
        inhibitory signalling in human immune responses

# ============================================================
# TAS/IMP: plasma membrane (Reactome and other)
# ============================================================

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-388829
  review:
    summary: &gt;-
      TAS from Reactome pathway &#34;SHP2 phosphatase binds CTLA-4&#34; (R-HSA-388829). CTLA4
      is at the plasma membrane where SHP-2 binds to its cytoplasmic tail. Well-supported.
    action: ACCEPT
    reason: &gt;-
      Correct localization. CTLA4 is a plasma membrane protein. Reactome annotation
      is consistent with extensive experimental evidence.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-388833
  review:
    summary: &gt;-
      TAS from Reactome pathway &#34;Phosphorylation of CTLA-4&#34; (R-HSA-388833). CTLA4 is
      phosphorylated at the plasma membrane.
    action: ACCEPT
    reason: &gt;-
      Correct localization. Consistent with other evidence.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IMP
  original_reference_id: PMID:28484017
  review:
    summary: &gt;-
      IMP for plasma membrane localization based on PMID:28484017 (Ramagopal et al. 2017).
      This study determined the crystal structure of ipilimumab bound to CTLA4 and
      performed cell-based binding assays with CTLA4 mutants, demonstrating CTLA4
      expression at the cell surface (plasma membrane). Mutagenesis of surface residues
      affected B7 ligand binding.
    action: ACCEPT
    reason: &gt;-
      The cell-based binding assays using CTLA4 mutants confirm plasma membrane localization
      and surface expression.
    supported_by:
    - reference_id: PMID:28484017
      supporting_text: &gt;-
        The crystallographically observed binding interface was confirmed by a comprehensive
        cell-based binding assay against a library of CTLA-4 mutants

- term:
    id: GO:0098636
    label: protein complex involved in cell adhesion
  evidence_type: IDA
  original_reference_id: PMID:7544393
  review:
    summary: &gt;-
      IDA for protein complex involved in cell adhesion. PMID:7544393 (Fargeas et al.
      1995) identified residues in the V domain of CD80 implicated in functional
      interactions with CD28 and CTLA4. CTLA4 does form complexes with B7 ligands at the
      cell surface in the immunological synapse, which could be considered cell adhesion-like.
      However, CTLA4 is fundamentally a signaling receptor rather than an adhesion molecule;
      its primary function is signal modulation rather than physical cell-cell adhesion.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      While CTLA4/B7 interactions occur at the T cell-APC interface, calling this &#34;cell
      adhesion&#34; is a stretch. CTLA4 functions primarily in signaling modulation rather than
      adhesion. The annotation may reflect CTLA4&#39;s participation in the immunological synapse,
      but the GO term is misleading for this protein&#39;s core function.
    supported_by:
    - reference_id: PMID:7544393
      supporting_text: &gt;-
        Two hydrophobic residues in the V-like domain of CD80 were identified as critical
        for binding to CD28 and are also important for the interaction with CTLA4

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-388809
  review:
    summary: &gt;-
      TAS from Reactome pathway &#34;CTLA-4 binds B7-1/B7-2&#34; (R-HSA-388809). CTLA4 binds
      B7 ligands at the plasma membrane.
    action: ACCEPT
    reason: &gt;-
      Correct localization consistent with all other evidence.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-389532
  review:
    summary: &gt;-
      TAS from Reactome pathway &#34;PP2A binds CTLA4 dimer&#34; (R-HSA-389532). PP2A interacts
      with CTLA4 at the plasma membrane.
    action: ACCEPT
    reason: &gt;-
      Correct localization consistent with all other evidence.

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8877421
  review:
    summary: &gt;-
      TAS from Reactome pathway &#34;CTLA4 gene expression is stimulated by FOXP3 and
      inhibited by RUNX1&#34; (R-HSA-8877421). This Reactome entry describes transcriptional
      regulation of CTLA4 by FOXP3 in Tregs.
    action: ACCEPT
    reason: &gt;-
      Correct. CTLA4 protein is ultimately targeted to the plasma membrane. The Reactome
      annotation reflects CTLA4 as a membrane protein in the context of Treg biology.

# ============================================================
# IMP annotations from PMID:17875758 (B-CLL study)
# ============================================================

- term:
    id: GO:0006974
    label: DNA damage response
  evidence_type: IMP
  original_reference_id: PMID:17875758
  review:
    summary: &gt;-
      IMP for DNA damage response based on PMID:17875758. This paper studied gene expression
      in CD38-high vs CD38-low B-CLL. The study found CTLA4 was differentially expressed and
      also examined ATM (a DNA damage response gene). However, the paper&#39;s focus was on gene
      expression profiling in CLL, and CTLA4 itself is not known to have a direct role in
      DNA damage response. The association appears to be correlative rather than functional.
      CTLA4 is not a DNA damage response gene -- it is an immune checkpoint receptor.
    action: REMOVE
    reason: &gt;-
      CTLA4 is not a DNA damage response protein. PMID:17875758 studied gene expression
      profiles in B-CLL and examined ATM alongside CTLA4, but did not demonstrate a direct
      role for CTLA4 in DNA damage response. This appears to be an over-interpretation
      of a gene expression study. CTLA4 has no known molecular role in DNA damage sensing,
      signaling, or repair. The deep research report (CTLA4-deep-research-falcon.md)
      describes CTLA4 exclusively as an immune checkpoint receptor with no mention of
      DNA damage function.
    supported_by:
    - reference_id: PMID:17875758
      supporting_text: &gt;-
        Gene expression analysis identified 76 differentially expressed genes in CD38 high
        versus low groups. Out of these genes, HEM1, CTLA4, and MNDA were selected for
        further studies

- term:
    id: GO:0030889
    label: negative regulation of B cell proliferation
  evidence_type: IMP
  original_reference_id: PMID:17875758
  review:
    summary: &gt;-
      IMP for negative regulation of B cell proliferation. PMID:17875758 found CTLA4
      overexpression was associated with good outcome in B-CLL (characterized by lower
      proliferative burden), and low CD38 CLL. However, this is a correlative observation
      from expression profiling rather than a direct functional assay showing CTLA4
      negatively regulates B cell proliferation. CTLA4 is primarily a T cell receptor.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      The evidence from PMID:17875758 is correlative gene expression data from CLL, not
      a direct demonstration that CTLA4 negatively regulates B cell proliferation. While
      CTLA4 expression has been reported on some B cells, and its overexpression correlates
      with better outcomes in B-CLL, this does not establish a direct mechanistic role in
      B cell proliferation regulation. CTLA4&#39;s primary function is T cell co-inhibition.
    supported_by:
    - reference_id: PMID:17875758
      supporting_text: &gt;-
        the overexpression of CTLA4 and MNDA was associated with good outcome

- term:
    id: GO:0043065
    label: positive regulation of apoptotic process
  evidence_type: IMP
  original_reference_id: PMID:17875758
  review:
    summary: &gt;-
      IMP for positive regulation of apoptotic process. PMID:17875758 studied gene
      expression in B-CLL. The paper found CTLA4 overexpression associated with good
      clinical outcomes, which could imply pro-apoptotic effects in CLL cells, but this
      is a correlative association from expression profiling, not a direct apoptosis assay.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      The evidence from PMID:17875758 is correlative. CTLA4 is not a direct positive
      regulator of apoptosis. While CTLA4 signaling in T cells can lead to T cell
      anergy (which is distinct from apoptosis), and CTLA4 expression in CLL correlates
      with better outcomes, this does not establish a direct pro-apoptotic molecular
      function for CTLA4.
    supported_by:
    - reference_id: PMID:17875758
      supporting_text: &gt;-
        the overexpression of CTLA4 and MNDA was associated with good outcome ...
        genes that may be involved in cell proliferation and survival

- term:
    id: GO:0050853
    label: B cell receptor signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:17875758
  review:
    summary: &gt;-
      IMP for B cell receptor signaling pathway. PMID:17875758 studied CTLA4 expression
      in B-CLL cells, which have constitutive BCR signaling. However, the paper demonstrates
      differential CTLA4 expression in CLL, not a direct role of CTLA4 in BCR signaling.
      CTLA4 is a co-inhibitory receptor for TCR signaling, not BCR signaling.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      PMID:17875758 is a gene expression study in B-CLL that does not demonstrate a
      mechanistic role for CTLA4 in BCR signaling. CTLA4 is expressed on some B cells
      but its primary signaling role is in T cells (TCR/CD28 pathway).
    supported_by:
    - reference_id: PMID:17875758
      supporting_text: &gt;-
        Gene expression analysis identified 76 differentially expressed genes in CD38
        high versus low groups

# ============================================================
# IDA: subcellular localizations from PMID:15814706
# ============================================================

- term:
    id: GO:0005794
    label: Golgi apparatus
  evidence_type: IDA
  original_reference_id: PMID:15814706
  review:
    summary: &gt;-
      IDA for Golgi apparatus localization. PMID:15814706 (Mead et al. 2005) showed that
      exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1,
      and is stimulated during activation of regulatory T cells. CTLA4 is known to traffic
      through the Golgi during biosynthesis and recycling. UniProt notes that CTLA4 exists
      primarily as an intracellular antigen with regulated trafficking. The deep research
      report (CTLA4-deep-research-falcon.md) confirms CTLA4 resides largely in intracellular
      vesicles at steady state.
    action: ACCEPT
    reason: &gt;-
      CTLA4 is a transmembrane glycoprotein that undergoes N-glycosylation (Asn-113,
      Asn-145) and traffics through the Golgi as part of its biosynthetic and recycling
      pathways. The annotation is consistent with known CTLA4 trafficking biology.
    supported_by:
    - reference_id: PMID:15814706
      supporting_text: &gt;-
        CTLA-4 was identified in a perinuclear compartment overlapping with the cis-Golgi
        marker GM-130 but did not colocalize strongly with lysosomal markers such as CD63
        and lysosome-associated membrane protein

- term:
    id: GO:0009897
    label: external side of plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:18641304
  review:
    summary: &gt;-
      IDA for external side of plasma membrane. PMID:18641304 (Zheng et al. 2008) showed
      that activated CD4+CD25- T cells express CTLA4 on their surface and acquire
      suppressive function. Flow cytometry detection of surface CTLA4 demonstrates
      external plasma membrane localization.
    action: ACCEPT
    reason: &gt;-
      Direct experimental evidence for surface expression of CTLA4, detected by flow
      cytometry on activated T cells.
    supported_by:
    - reference_id: PMID:18641304
      supporting_text: &gt;-
        Acquisition of suppressive function by activated human CD4+ CD25- T cells is
        associated with the expression of CTLA-4 not FoxP3

- term:
    id: GO:0045334
    label: clathrin-coated endocytic vesicle
  evidence_type: IDA
  original_reference_id: PMID:15814706
  review:
    summary: &gt;-
      IDA for clathrin-coated endocytic vesicle localization. CTLA4 is known to undergo
      constitutive clathrin-mediated endocytosis. Its cytoplasmic YVKM motif interacts
      with the AP-2 adaptor complex, and phosphorylation at Tyr-201 regulates this
      interaction (PMID:9175836). PMID:15814706 (Mead et al. 2005) studied CTLA4 exocytosis
      and trafficking in regulatory T cells.
    action: ACCEPT
    reason: &gt;-
      CTLA4 is constitutively endocytosed via clathrin-mediated endocytosis. The YVKM
      motif in the cytoplasmic tail binds AP-2, and its localization in clathrin-coated
      vesicles is well-established. This annotation is consistent with known CTLA4
      trafficking biology.
    supported_by:
    - reference_id: PMID:15814706
      supporting_text: &gt;-
        expression of CTLA-4 at the plasma membrane (PM) is controlled by exocytosis of
        CTLA-4-containing vesicles and followed by rapid endocytosis

- term:
    id: GO:0045590
    label: negative regulation of regulatory T cell differentiation
  evidence_type: IDA
  original_reference_id: PMID:18641304
  review:
    summary: &gt;-
      IDA for negative regulation of Treg differentiation. PMID:18641304 showed that
      CTLA4 expression (rather than FoxP3) is associated with acquisition of suppressive
      function by activated CD4+CD25- T cells, suggesting CTLA4 modulates the threshold
      for Treg-like function.
    action: ACCEPT
    reason: &gt;-
      Consistent with the IBA annotation for the same term. PMID:18641304 provides
      direct evidence that CTLA4 expression modulates T cell suppressive function and
      Treg differentiation.
    supported_by:
    - reference_id: PMID:18641304
      supporting_text: &gt;-
        Acquisition of suppressive function by activated human CD4+ CD25- T cells is
        associated with the expression of CTLA-4 not FoxP3

- term:
    id: GO:0048471
    label: perinuclear region of cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:15814706
  review:
    summary: &gt;-
      IDA for perinuclear region of cytoplasm localization. CTLA4 is known to accumulate
      in intracellular compartments, including the perinuclear region, at steady state due
      to constitutive endocytosis. UniProt notes CTLA4 &#34;exists primarily as an intracellular
      antigen.&#34; PMID:15814706 (Mead et al. 2005) demonstrated CTLA4 trafficking and
      subcellular distribution in T cells.
    action: ACCEPT
    reason: &gt;-
      Consistent with known CTLA4 cell biology. At steady state, the majority of CTLA4
      resides intracellularly in perinuclear vesicular compartments, with rapid
      endocytosis maintaining low surface expression.
    supported_by:
    - reference_id: PMID:15814706
      supporting_text: &gt;-
        CTLA-4 was identified in a perinuclear compartment overlapping with the cis-Golgi
        marker GM-130

# ============================================================
# TAS: plasma membrane and immune response (PMID:3220103)
# ============================================================

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: PMID:3220103
  review:
    summary: &gt;-
      TAS for plasma membrane localization from PMID:3220103 (Dariavach et al. 1988).
      This is the original paper that identified CTLA4 as a human Ig superfamily member
      and determined its chromosomal location. The sequence predicts a transmembrane
      protein localized to the plasma membrane.
    action: ACCEPT
    reason: &gt;-
      The original characterization paper identifying CTLA4 as a membrane protein.
      Consistent with all subsequent experimental evidence.
    supported_by:
    - reference_id: PMID:3220103
      supporting_text: &gt;-
        The first exon encodes a V-like domain of 116 amino acids, the second one a
        hydrophobic putative transmembrane region of 37 amino acids and the third one a
        34 amino acid putative cytoplasmic domain

- term:
    id: GO:0006955
    label: immune response
  evidence_type: TAS
  original_reference_id: PMID:3220103
  review:
    summary: &gt;-
      TAS for immune response from PMID:3220103. The original characterization paper
      identifies CTLA4 as an Ig superfamily member expressed in lymphocytes, implying
      immune function.
    action: ACCEPT
    reason: &gt;-
      Broad but correct. CTLA4 is clearly involved in immune response. More specific
      terms provide detail.
    supported_by:
    - reference_id: PMID:3220103
      supporting_text: &gt;-
        The mouse CTLA-4 gene has been shown to code for an activated
        lymphocyte-associated sequence belonging to the Ig gene superfamily

# ============================================================
# NEW annotations suggested
# ============================================================

- term:
    id: GO:0030547
    label: signaling receptor inhibitor activity
  evidence_type: IDA
  original_reference_id: PMID:11279501
  review:
    summary: &gt;-
      CTLA4 functions as an inhibitor of CD28 signaling receptor activity by competitively
      binding B7 ligands (CD80/CD86) with higher avidity, preventing CD28 from receiving
      co-stimulatory signals. This is a core molecular function. GO:0030547 is defined as
      &#34;Binds to and modulates the activity of a signaling receptor&#34; -- CTLA4 modulates
      CD28 activity by sequestering its ligands.
    action: NEW
    reason: &gt;-
      This molecular function term more accurately describes how CTLA4 functionally
      inhibits CD28 signaling. While receptor decoy activity (GO:0140319) captures the
      ligand sequestration, signaling receptor inhibitor activity captures the functional
      consequence on CD28. Together these provide a more complete picture of CTLA4
      molecular function than the generic &#34;protein binding&#34; annotations currently in place.
    supported_by:
    - reference_id: PMID:11279501
      supporting_text: &gt;-
        Engagement of CD28 with B7-1 and B7-2 ligands on antigen-presenting cells (APCs)
        provides a stimulatory signal for T-cell activation, whereas subsequent engagement
        of CTLA-4 with these same ligands results in attenuation of the response
    - reference_id: PMID:11279502
      supporting_text: &gt;-
        Signalling through CD28 augments the T-cell response, whereas CTLA-4 signalling
        attenuates it

references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: PMID:3220103
  title: Human Ig superfamily CTLA-4 gene chromosomal localization and identity of protein
    sequence between murine and human CTLA-4 cytoplasmic domains.
  findings:
  - statement: Original characterization of human CTLA4 as an Ig superfamily member on chromosome 2.
    supporting_text: &gt;-
      Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein
      sequence between murine and human CTLA-4 cytoplasmic domains
- id: PMID:7544393
  title: Identification of residues in the V domain of CD80 (B7-1) implicated in functional
    interactions with CD28 and CTLA4.
  findings:
  - statement: Identified CD80 residues important for binding CD28 and CTLA4.
    supporting_text: &gt;-
      Identification of residues in the V domain of CD80 (B7-1) implicated in functional
      interactions with CD28 and CTLA4
- id: PMID:7807015
  title: CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells.
  findings:
  - statement: Demonstrated interaction between CTLA4 cytoplasmic tail and PI3K p85 subunit.
    supporting_text: &gt;-
      CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells
- id: PMID:9175836
  title: Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its
    interaction with clathrin-associated adaptor complex AP-2.
  findings:
  - statement: Phosphorylation of Tyr-201 in YVKM motif prevents AP-2 binding and blocks endocytosis.
    supporting_text: &gt;-
      Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its
      interaction with clathrin-associated adaptor complex AP-2
- id: PMID:9398332
  title: Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated
    protein is negatively regulated by tyrosine phosphorylation.
  findings:
  - statement: Further evidence for CTLA4-PI3K p85 interaction and clathrin-associated protein binding.
    supporting_text: &gt;-
      Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated
      protein is negatively regulated by tyrosine phosphorylation
- id: PMID:9813138
  title: Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates
    PI 3-kinase binding to T-cell antigen CTLA-4.
  findings:
  - statement: Rlk/Txk phosphorylates CTLA4 YVKM motif, regulating PI3K binding.
    supporting_text: &gt;-
      Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates
      PI 3-kinase binding to T-cell antigen CTLA-4
- id: PMID:11279501
  title: Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
  findings:
  - statement: &gt;-
      3.2A crystal structure of CTLA4/B7-2 complex reveals bivalent network formation at
      the immunological synapse, providing structural basis for CTLA4 inhibitory function.
    supporting_text: &gt;-
      the 3.2-A resolution structure of the complex between the disulphide-linked
      homodimer of human CTLA-4 and the receptor-binding domain of human B7-2
- id: PMID:11279502
  title: Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
  findings:
  - statement: &gt;-
      3.0A crystal structure of CTLA4/B7-1 complex reveals zipper-like oligomerization
      forming stable inhibitory signaling complexes.
    supporting_text: &gt;-
      CTLA-4 and B7-1 pack in a strikingly periodic arrangement in which bivalent
      CTLA-4 homodimers bridge bivalent B7-1 homodimers
- id: PMID:15814706
  title: Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation
    factor-1 and stimulated during activation of regulatory T cells.
  findings:
  - statement: CTLA4 localizes to Golgi, clathrin-coated vesicles, and perinuclear region;
      exocytosis is PLD and ARF1 dependent.
    supporting_text: &gt;-
      Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1
      and stimulated during activation of regulatory T cells
- id: PMID:16551244
  title: A molecular perspective of CTLA-4 function.
  findings:
  - statement: Comprehensive review of CTLA4 molecular function, trafficking, and signaling.
    supporting_text: &gt;-
      A molecular perspective of CTLA-4 function
- id: PMID:17875758
  title: ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic
    lymphocytic leukemia.
  findings:
  - statement: &gt;-
      Gene expression profiling in B-CLL identified CTLA4 overexpression associated with
      good clinical outcome in CD38-low CLL. Study is correlative rather than mechanistic.
    supporting_text: &gt;-
      the overexpression of CTLA4 and MNDA was associated with good outcome
- id: PMID:18468488
  title: CTLA-4 trafficking and surface expression.
  findings:
  - statement: &gt;-
      Review of CTLA4 constitutive endocytosis, recycling, and regulated surface expression.
    supporting_text: &gt;-
      CTLA-4 trafficking and surface expression
- id: PMID:18641304
  title: Acquisition of suppressive function by activated human CD4+ CD25- T cells is
    associated with the expression of CTLA-4 not FoxP3.
  findings:
  - statement: &gt;-
      CTLA4 expression, not FoxP3, associated with acquisition of suppressive function by
      activated CD4+CD25- T cells. Surface CTLA4 detected by flow cytometry.
    supporting_text: &gt;-
      Acquisition of suppressive function by activated human CD4+ CD25- T cells is
      associated with the expression of CTLA-4 not FoxP3
- id: PMID:20587542
  title: PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
  findings:
  - statement: Confirmed CTLA4-CD80 interaction.
    supporting_text: &gt;-
      PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
- id: PMID:21982860
  title: A secreted protein microarray platform for extracellular protein interaction discovery.
  findings:
  - statement: Confirmed CTLA4 interactions with CD80 and CD86.
    supporting_text: &gt;-
      A secreted protein microarray platform for extracellular protein interaction discovery
- id: PMID:25241761
  title: Using an in situ proximity ligation assay to systematically profile endogenous
    protein-protein interactions in a pathway network.
  findings:
  - statement: Confirmed CTLA4-CD86 interaction by proximity ligation assay.
    supporting_text: &gt;-
      Using an in situ proximity ligation assay to systematically profile endogenous
      protein-protein interactions in a pathway network
- id: PMID:26206937
  title: AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune
    dysregulation responsive to abatacept therapy.
  findings:
  - statement: Demonstrated CTLA4-LRBA interaction important for CTLA4 trafficking and stability.
    supporting_text: &gt;-
      Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive
      to abatacept therapy
- id: PMID:28484017
  title: Structural basis for cancer immunotherapy by the first-in-class checkpoint
    inhibitor ipilimumab.
  findings:
  - statement: &gt;-
      3.0A crystal structure of ipilimumab bound to CTLA4 shows steric overlap with B7
      ligand binding site. Cell-based mutant binding assays confirm surface expression and
      interaction determinants.
    supporting_text: &gt;-
      The crystallographically observed binding interface was confirmed by a comprehensive
      cell-based binding assay against a library of CTLA-4 mutants
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings:
  - statement: High-throughput binary interactome mapping detecting CTLA4 interactions.
    supporting_text: &gt;-
      A reference map of the human binary protein interactome
- id: PMID:32822567
  title: A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein
    Interactions.
  findings:
  - statement: Confirmed CTLA4-CD80 and CTLA4-CD86 interactions.
    supporting_text: &gt;-
      A Human IgSF Cell-Surface Interactome Reveals a Complex Network of Protein-Protein
      Interactions
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
  findings:
  - statement: Confirmed CTLA4-LRBA interaction.
    supporting_text: &gt;-
      Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
- id: PMID:35922511
  title: A physical wiring diagram for the human immune system.
  findings:
  - statement: Confirmed CTLA4-CD80 and CTLA4-CD86 interactions.
    supporting_text: &gt;-
      A physical wiring diagram for the human immune system
- id: PMID:40205054
  title: Multimodal cell maps as a foundation for structural and functional genomics.
  findings:
  - statement: Confirmed CTLA4-LRBA interaction.
    supporting_text: &gt;-
      Multimodal cell maps as a foundation for structural and functional genomics
- id: Reactome:R-HSA-388809
  title: CTLA-4 binds B7-1/B7-2
  findings: []
- id: Reactome:R-HSA-388829
  title: SHP2 phosphatase binds CTLA-4
  findings: []
- id: Reactome:R-HSA-388833
  title: Phosphorylation of CTLA-4
  findings: []
- id: Reactome:R-HSA-389532
  title: PP2A binds CTLA4 dimer
  findings: []
- id: Reactome:R-HSA-8877421
  title: CTLA4 gene expression is stimulated by FOXP3 and inhibited by RUNX1
  findings: []
- id: file:human/CTLA4/CTLA4-deep-research-falcon.md
  title: Deep research report on CTLA4 function, trafficking, and clinical applications.
  findings:
  - statement: &gt;-
      CTLA4 is a canonical Ig-superfamily inhibitory receptor that enforces early checkpoint
      control of T-cell priming via high-avidity binding to CD80/CD86 and Treg-mediated
      trans-endocytosis of these ligands.
    supporting_text: &gt;-
      CTLA-4 inhibits T-cell activation primarily by binding CD80/CD86 with higher avidity
      than CD28, thereby limiting signal 2 co-stimulation and inducing tolerance/anergy at
      the priming phase in lymphoid tissues
core_functions:
- molecular_function:
    id: GO:0140319
    label: receptor decoy activity
  directly_involved_in:
  - id: GO:0050868
    label: negative regulation of T cell activation
  - id: GO:0050860
    label: negative regulation of T cell receptor signaling pathway
  locations:
  - id: GO:0009897
    label: external side of plasma membrane
  description: &gt;-
    CTLA4 acts as a decoy receptor by binding B7 ligands (CD80/B7-1 and CD86/B7-2) on
    antigen-presenting cells with higher avidity than the co-stimulatory receptor CD28,
    thereby sequestering these ligands and preventing CD28-mediated co-stimulation of
    T cells. This competitive inhibition is the primary molecular function of CTLA4,
    resulting in negative regulation of T cell activation and TCR signaling.
  supported_by:
  - reference_id: PMID:11279501
    supporting_text: &gt;-
      the 3.2-A resolution structure of the complex between the disulphide-linked
      homodimer of human CTLA-4 and the receptor-binding domain of human B7-2
  - reference_id: PMID:11279502
    supporting_text: &gt;-
      This zipper-like oligomerization provides the structural basis for forming
      unusually stable signalling complexes at the T-cell surface, underscoring the
      importance of potent inhibitory signalling in human immune responses
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>